Molecular	O
and	O
cellular	O
analysis	O
of	O
human	O
immunodeficiency	O
virus-induced	O
apoptosis	O
in	O
lymphoblastoid	B-protein
T-cell-line-expressing	I-protein
wild-type	I-protein
and	I-protein
mutated	I-protein
CD4	I-protein
receptors	I-protein
.	O

We	O
have	O
previously	O
shown	O
that	O
the	O
presence	O
of	O
the	O
CD4	B-protein
cytoplasmic	I-protein
tail	I-protein
is	O
critical	O
for	O
human	O
immunodeficiency	O
virus	O
(	O
HIV	O
)	O
-induced	O
apoptosis	O
(	O
J.Corbeil	O
,	O
M.Tremblay	O
,	O
and	O
D.D.Richman	O
,	O
J.Exp.Med.183	O
:	O
39-48	O
,	O
1996	O
)	O
.	O

We	O
have	O
pursued	O
our	O
investigation	O
of	O
the	O
role	O
of	O
the	O
CD4	B-protein
transduction	O
pathway	O
in	O
HIV-induced	O
apoptosis	O
.	O

To	O
do	O
this	O
,	O
wild-type	O
and	O
mutant	O
forms	O
of	O
the	O
CD4	B-protein
cytoplasmic	I-protein
tail	I-protein
were	O
stably	O
expressed	O
in	O
the	O
lymphoblastoid	B-cell_line
T-cell	I-cell_line
line	I-cell_line
A2.01	B-cell_line
.	O

Apoptosis	O
was	O
prevented	O
when	O
CD4	B-protein
truncated	O
at	O
residue	O
402	O
was	O
expressed	O
;	O
however	O
,	O
cells	O
expressing	O
mutated	O
receptors	O
that	O
do	O
not	O
associate	O
with	O
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
(	O
mutated	O
at	O
the	O
dicysteine	B-protein
motif	I-protein
and	O
truncated	O
at	O
residue	O
418	O
)	O
but	O
which	O
conserved	O
proximal	O
domains	O
of	O
the	O
cytoplasmic	B-protein
tail	I-protein
underwent	O
apoptosis	O
like	O
wild-	B-protein
type	I-protein
CD4	I-protein
.	O

The	O
differences	O
between	O
wild-type	B-protein
and	I-protein
mutated	I-protein
receptors	I-protein
in	O
the	O
induction	O
of	O
apoptosis	O
were	O
not	O
related	O
to	O
levels	O
of	O
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
or	O
NF-	B-protein
kappaB	I-protein
activation	O
.	O

Initial	O
signaling	O
through	O
the	O
CD4	B-protein
receptor	I-protein
played	O
a	O
major	O
role	O
in	O
the	O
sensitization	O
of	O
HIV-infected	B-cell_type
T	I-cell_type
cells	I-cell_type
to	O
undergo	O
apoptosis	O
.	O

Incubation	O
of	O
HIV-infected	B-cell_type
cells	I-cell_type
with	O
monoclonal	B-protein
antibody	I-protein
(	I-protein
MAb	I-protein
)	I-protein
13B8-2	I-protein
,	O
which	O
binds	O
to	O
CD4	B-protein
in	O
a	O
region	O
critical	O
for	O
dimerization	O
of	O
the	O
receptor	O
,	O
prevented	O
apoptosis	O
without	O
inhibiting	O
HIV	O
replication	O
.	O

Moreover	O
,	O
the	O
apoptotic	O
process	O
was	O
not	O
related	O
to	O
Fas	B-protein
-Fas	B-protein
ligand	I-protein
interaction	O
;	O
however	O
,	O
an	O
antagonistic	O
anti-Fas	O
MAb	O
(	O
ZB-4	O
)	O
enhanced	O
apoptosis	O
in	O
HIV-infected	B-cell_type
cells	I-cell_type
without	O
inducing	O
apoptosis	O
in	O
uninfected	B-cell_type
cells	I-cell_type
.	O

These	O
observations	O
demonstrate	O
that	O
CD4	B-protein
signaling	O
mediates	O
HIV-induced	O
apoptosis	O
by	O
a	O
mechanism	O
independent	O
of	O
Fas	B-protein
-Fas	B-protein
ligand	I-protein
interaction	O
,	O
does	O
not	O
require	O
p56	B-protein
(	I-protein
lck	I-protein
)	I-protein
signaling	O
,	O
and	O
may	O
involve	O
a	O
critical	O
region	O
for	O
CD4	B-protein
dimerization	O
.	O

JOURNAL	NULL
or	NULL
ViroLoGy	NULL
,	NULL
Oct.	NULL
1998	NULL
,	NULL
p.	NULL
8061-8072	NULL
0022-538	NULL
X	NULL
,	NULL
/98/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

72	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Copyright	NULL
©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

Molecular	NULL
and	NULL
Cellular	NULL
Analysis	NULL
of	NULL
Human	NULL
Immunodeficiency	NULL
Virus-Induced	NULL
Apoptosis	NULL
in	NULL
Lymphoblastoid	NULL
T-Cell-Line-Expressing	NULL
Wild-Type	NULL
and	NULL
Mutated	NULL
CD4	NULL
Receptors	NULL
LAURE	NULL
MOUTOUH	NULL
,	NULL
'	NULL
JEROME	NULL
ESTAQUIER,2	NULL
DOUGLAS	NULL
D.	NULL
RICHMAN	NULL
,	NULL
*	NULL
anp	NULL
JACQUES	NULL
CORBEIL'*	NULL
Departments	NULL
of	NULL
Pathology	NULL
and	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California	NULL
San	NULL
Diego	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
California	NULL
92093-0679	NULL
;	NULL
INSERM	NULL
CJF	NULL
97-07	NULL
,	NULL
Groupe	NULL
Hospitalier	NULL
Claude-Bernard	NULL
Bichat	NULL
,	NULL
75877	NULL
Paris	NULL
,	NULL
France	NULL
``	NULL
;	NULL
and	NULL
San	NULL
Diego	NULL
Veterans	NULL
Affairs	NULL
Medical	NULL
Center	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
California	NULL
92161°	NULL
Received	NULL
13	NULL
January	NULL
1998/Accepted	NULL
17	NULL
June	NULL
1998	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
critical	NULL
for	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
-induced	NULL
apoptosis	NULL
(	NULL
J.	NULL
Corbeil	NULL
,	NULL
M.	NULL
Tremblay	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Richman	NULL
,	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:39-48	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
have	NULL
pursued	NULL
our	NULL
investigation	NULL
of	NULL
the	NULL
role	NULL
of	NULL
the	NULL
CD4	NULL
transduction	NULL
pathway	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

To	NULL
do	NULL
this	NULL
,	NULL
wild-type	NULL
and	NULL
mutant	NULL
forms	NULL
of	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
were	NULL
stably	NULL
expressed	NULL
in	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
.	NULL

Apoptosis	NULL
was	NULL
prevented	NULL
when	NULL
CD4	NULL
truncated	NULL
at	NULL
residue	NULL
402	NULL
was	NULL
expressed	NULL
;	NULL
however	NULL
,	NULL
cells	NULL
expressing	NULL
mutated	NULL
receptors	NULL
that	NULL
do	NULL
not	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
(	NULL
mutated	NULL
at	NULL
the	NULL
dicysteine	NULL
motif	NULL
and	NULL
truncated	NULL
at	NULL
residue	NULL
418	NULL
)	NULL
but	NULL
which	NULL
conserved	NULL
proximal	NULL
domains	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
underwent	NULL
apoptosis	NULL
like	NULL
wild-type	NULL
CD4	NULL
.	NULL

The	NULL
differences	NULL
between	NULL
wild-type	NULL
and	NULL
mutated	NULL
receptors	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
were	NULL
not	NULL
related	NULL
to	NULL
levels	NULL
of	NULL
p56**	NULL
or	NULL
NF-B	NULL
activation	NULL
.	NULL

Initial	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
played	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
sensitization	NULL
of	NULL
HIV-infected	NULL
T	NULL
cells	NULL
to	NULL
undergo	NULL
apoptosis	NULL
.	NULL

Incubation	NULL
of	NULL
HIV-infected	NULL
cells	NULL
with	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
13B8-2	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
CD4	NULL
in	NULL
a	NULL
region	NULL
critical	NULL
for	NULL
dimerization	NULL
of	NULL
the	NULL
receptor	NULL
,	NULL
prevented	NULL
apoptosis	NULL
without	NULL
inhibiting	NULL
HIV	NULL
replication	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
apoptotic	NULL
process	NULL
was	NULL
not	NULL
related	NULL
to	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
;	NULL
however	NULL
,	NULL
an	NULL
antagonistic	NULL
anti-Fas	NULL
MAb	NULL
(	NULL
ZB-4	NULL
)	NULL
enhanced	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
without	NULL
inducing	NULL
apoptosis	NULL
in	NULL
uninfected	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
demonstrate	NULL
that	NULL
CD4	NULL
signaling	NULL
mediates	NULL
HIV-induced	NULL
apoptosis	NULL
by	NULL
a	NULL
mechanism	NULL
independent	NULL
of	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
,	NULL
does	NULL
not	NULL
require	NULL
p56	NULL
``	NULL
signaling	NULL
,	NULL
and	NULL
may	NULL
involve	NULL
a	NULL
critical	NULL
region	NULL
for	NULL
CD4	NULL
dimerization	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
HIV	NULL
)	NULL
infection	NULL
in	NULL
vivo	NULL
is	NULL
characterized	NULL
by	NULL
high	NULL
levels	NULL
of	NULL
continuous	NULL
viral	NULL
replication	NULL
(	NULL
19	NULL
,	NULL
39	NULL
,	NULL
40	NULL
,	NULL
72	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
CD4	NULL
cells	NULL
in	NULL
HIV-infected	NULL
patients	NULL
are	NULL
undergoing	NULL
a	NULL
dynamic	NULL
process	NULL
with	NULL
increased	NULL
levels	NULL
of	NULL
destruction	NULL
and	NULL
replacement	NULL
to	NULL
maintain	NULL
steady	NULL
state	NULL
.	NULL

Virus	NULL
replication	NULL
may	NULL
be	NULL
directly	NULL
involved	NULL
in	NULL
the	NULL
destruction	NULL
of	NULL
HIV-infected	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
is	NULL
a	NULL
general	NULL
state	NULL
of	NULL
immune	NULL
system	NULL
activation	NULL
in	NULL
HIV-infected	NULL
patients	NULL
that	NULL
contributes	NULL
to	NULL
enhanced	NULL
apoptosis	NULL
of	NULL
both	NULL
infected	NULL
and	NULL
bystander	NULL
cells	NULL
in	NULL
vivo	NULL
(	NULL
27	NULL
,	NULL
55	NULL
)	NULL
.	NULL

Apoptosis	NULL
is	NULL
a	NULL
cellular	NULL
suicide	NULL
process	NULL
regulated	NULL
by	NULL
both	NULL
internal	NULL
and	NULL
external	NULL
factors	NULL
(	NULL
56	NULL
,	NULL
68	NULL
)	NULL
.	NULL

The	NULL
various	NULL
stimuli	NULL
triggering	NULL
apoptosis	NULL
are	NULL
assumed	NULL
to	NULL
converge	NULL
to	NULL
a	NULL
common	NULL
executioner	NULL
pathway	NULL
that	NULL
involves	NULL
the	NULL
release	NULL
of	NULL
cytochrome	NULL
c	NULL
from	NULL
the	NULL
mitochondria	NULL
into	NULL
the	NULL
cytoplasm	NULL
and	NULL
activation	NULL
of	NULL
caspase	NULL
family	NULL
proteases	NULL
(	NULL
2	NULL
,	NULL
38	NULL
,	NULL
64	NULL
)	NULL
.	NULL

The	NULL
cellular	NULL
changes	NULL
associated	NULL
with	NULL
apoptosis	NULL
include	NULL
exposure	NULL
of	NULL
phosphatidylserine	NULL
on	NULL
the	NULL
plasma	NULL
membrane	NULL
externally	NULL
and	NULL
nuclear	NULL
damage	NULL
typified	NULL
by	NULL
chromatin	NULL
condensation	NULL
and	NULL
oligonucleosomal	NULL
DNA	NULL
fragmentation	NULL
.	NULL

Apoptosis	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
HIV	NULL
cytopathology	NULL
in	NULL
vitro	NULL
(	NULL
35	NULL
,	NULL
49	NULL
,	NULL
67	NULL
)	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
CD4	NULL
*-T-cell	NULL
depletion	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
HIV	NULL
env	NULL
gene	NULL
products	NULL
gp120	NULL
and	NULL
gp41	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
apoptosis	NULL
by	NULL
engagement	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
(	NULL
50	NULL
)	NULL
,	NULL
while	NULL
cross-linking	NULL
of	NULL
bound	NULL
gp120	NULL
and	NULL
T-cell	NULL
receptor	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
prime	NULL
for	NULL
activation-induced	NULL
apoptosis	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Other	NULL
viral	NULL
genes	NULL
like	NULL
tot	NULL
may	NULL
accelerate	NULL
Fas-medi-	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
University	NULL
of	NULL
California	NULL
San	NULL
Diego	NULL
,	NULL
Clinical	NULL
Sciences	NULL
Bldg	NULL
.	NULL

,	NULL
Rm	NULL
.	NULL

325	NULL
,	NULL
9500	NULL
Gilman	NULL
Dr.	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
92093-0679	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
619	NULL
)	NULL
552-4339	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
619	NULL
)	NULL
552-7445	NULL
.	NULL

E-mail	NULL
:	NULL
jcorbeil	NULL
@	NULL
uesd.edu	NULL
.	NULL

8061	NULL
ated	NULL
apoptosis	NULL
in	NULL
association	NULL
with	NULL
gp120	NULL
(	NULL
74	NULL
)	NULL
.	NULL

vypr	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
inducing	NULL
or	NULL
suppressing	NULL
apoptosis	NULL
(	NULL
3	NULL
,	NULL
59	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Signaling	NULL
through	NULL
Fas	NULL
may	NULL
contribute	NULL
significantly	NULL
to	NULL
T-cell	NULL
depletion	NULL
in	NULL
HIV-1-infected	NULL
patients	NULL
(	NULL
6	NULL
,	NULL
24	NULL
,	NULL
25	NULL
,	NULL
45	NULL
)	NULL
;	NULL
however	NULL
,	NULL
the	NULL
role	NULL
of	NULL
Fas	NULL
in	NULL
inducing	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
fully	NULL
characterized	NULL
.	NULL

The	NULL
potency	NULL
of	NULL
the	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
to	NULL
induce	NULL
apoptosis	NULL
appears	NULL
to	NULL
differ	NULL
between	NULL
T-cell	NULL
lines	NULL
and	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
32	NULL
,	NULL
57	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
that	NULL
productive	NULL
HIV-1	NULL
infection	NULL
triggered	NULL
apoptosis	NULL
in	NULL
lymphoblastoid	NULL
T-cell	NULL
lines	NULL
and	NULL
that	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
CD4	NULL
was	NULL
required	NULL
for	NULL
apoptosis	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
HIV-induced	NULL
apoptosis	NULL
was	NULL
prevented	NULL
in	NULL
cells	NULL
expressing	NULL
a	NULL
truncated	NULL
CD4	NULL
mutant	NULL
that	NULL
lacks	NULL
the	NULL
whole	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
truncation	NULL
at	NULL
residue	NULL
402	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
the	NULL
CD4	NULL
signaling	NULL
and	NULL
Fas	NULL
signaling	NULL
pathways	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
A2.01	NULL
lymphoblastoid	NULL
T	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
receptors	NULL
.	NULL

We	NULL
also	NULL
addressed	NULL
the	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
control	NULL
of	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
recep-tors	NULL
,	NULL
since	NULL
NF-KB	NULL
activation	NULL
modulates	NULL
apoptosis	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
34	NULL
,	NULL
52	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
is	NULL
functionally	NULL
important	NULL
for	NULL
CD4-mediated	NULL
signal	NULL
transduction	NULL
during	NULL
T-cell	NULL
activation	NULL
(	NULL
31	NULL
,	NULL
71	NULL
)	NULL
.	NULL

This	NULL
function	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
association	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p56**	NULL
with	NULL
CD4	NULL
(	NULL
69	NULL
,	NULL
70	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
the	NULL
association	NULL
of	NULL
CD4	NULL
with	NULL
p56	NULL
was	NULL
required	NULL
for	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
.	NULL

HIV-infected	NULL
cells	NULL
expressing	NULL
CD4	NULL
constructs	NULL
that	NULL
did	NULL
not	NULL
associate	NULL
with	NULL
p56**	NULL
but	NULL
conserved	NULL
all	NULL
or	NULL
part	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
substi-tution	NULL
in	NULL
the	NULL
dicysteine	NULL
motif	NULL
and	NULL
truncation	NULL
at	NULL
residue	NULL
418	NULL
,	NULL
respectively	NULL
)	NULL
underwent	NULL
apoptosis	NULL
.	NULL

Moreover	NULL
,	NULL
p56**	NULL
signaling	NULL
was	NULL
not	NULL
rescued	NULL
in	NULL
cells	NULL
expressing	NULL
CD4	NULL
mutants	NULL
that	NULL
do	NULL
not	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
~*	NULL
,	NULL
demonstrating	NULL
that	NULL
p56	NULL
``	NULL
**	NULL
signaling	NULL
is	NULL
dis	NULL
8062	NULL
MOUTOUH	NULL
ET	NULL
AL	NULL
.	NULL

pensable	NULL
for	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
.	NULL

Initial	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
was	NULL
found	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

Prolonged	NULL
presence	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
HIV-infected	NULL
cells	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
enhance	NULL
the	NULL
level	NULL
of	NULL
apoptosis	NULL
.	NULL

The	NULL
anti-CD4	NULL
antibody	NULL
13B8-2	NULL
that	NULL
interacts	NULL
with	NULL
a	NULL
critical	NULL
region	NULL
for	NULL
CD4	NULL
dimerization	NULL
was	NULL
able	NULL
to	NULL
prevent	NULL
the	NULL
apoptosis	NULL
of	NULL
productively	NULL
HIV-infected	NULL
cells	NULL
while	NULL
not	NULL
inhibiting	NULL
virus	NULL
replication	NULL
,	NULL
corroborating	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
CD4	NULL
signaling	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

HIV-induced	NULL
apoptosis	NULL
was	NULL
not	NULL
mediated	NULL
by	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
,	NULL
since	NULL
the	NULL
Fas-Fc	NULL
decoy	NULL
was	NULL
unable	NULL
to	NULL
prevent	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Antibodies	NULL
.	NULL

Murine	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
OKT-4	NULL
(	NULL
anti-human	NULL
CD4	NULL
)	NULL
was	NULL
used	NULL
as	NULL
ascites	NULL
(	NULL
hybridoma	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
.	NULL

The	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-labeled	NULL
OKT4	NULL
MAb	NULL
and	NULL
the	NULL
13B8-2	NULL
MAb	NULL
were	NULL
purchased	NULL
from	NULL
Johnson	NULL
&	NULL
Johnson	NULL
(	NULL
Raritan	NULL
,	NULL
N.J.	NULL
)	NULL
and	NULL
Immunotech	NULL
Inc.	NULL
(	NULL
Westbrook	NULL
,	NULL
Maine	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
immunoglobulin	NULL
G	NULL
(	NULL
IgG	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Biosource	NULL
International	NULL
(	NULL
Camarillo	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
rabbit	NULL
antiserum	NULL
against	NULL
Ick	NULL
and	NULL
the	NULL
peroxidase-coupled	NULL
polyclonal	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
were	NULL
purchased	NULL
from	NULL
Pharmingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

4G10	NULL
MAb	NULL
(	NULL
antiphosphotyrosine	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
(	NULL
Lake	NULL
Placid	NULL
,	NULL
N.Y.	NULL
)	NULL
.	NULL

Peroxidase-labeled	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
was	NULL
obtained	NULL
from	NULL
The	NULL
Binding	NULL
Site	NULL
Inc.	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Fab	NULL
'	NULL
)	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
Biosource	NULL
International	NULL
.	NULL

The	NULL
agonistic	NULL
CD95	NULL
IgM	NULL
MAb	NULL
(	NULL
clone	NULL
CH-11	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
.	NULL

The	NULL
soluble	NULL
Fas	NULL
receptor	NULL
decoy	NULL
(	NULL
human	NULL
Fas-Fc	NULL
Ig	NULL
fusion	NULL
protein	NULL
)	NULL
was	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
C.	NULL
Ware	NULL
(	NULL
La	NULL
Jolla	NULL
Institute	NULL
for	NULL
Allergy	NULL
and	NULL
Immunology	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
anti-Fas	NULL
IgG1	NULL
antibody	NULL
clone	NULL
ZB4	NULL
was	NULL
from	NULL
Immunotech	NULL
Inc	NULL
.	NULL

The	NULL
biotin-conjugated	NULL
mouse	NULL
anti-human	NULL
Fas	NULL
ligand	NULL
MAb	NULL
(	NULL
clone	NULL
NOK-1	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Pharmingen	NULL
.	NULL

Generation	NULL
of	NULL
stably	NULL
transfected	NULL
CD4	NULL
cell	NULL
lines	NULL
.	NULL

Plasmids	NULL
encoding	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
receptors	NULL
that	NULL
interfere	NULL
with	NULL
Nef-associated	NULL
motifs	NULL
(	NULL
LL-to-AA	NULL
substitution	NULL
in	NULL
the	NULL
dileucine	NULL
motif	NULL
at	NULL
residues	NULL
413	NULL
and	NULL
414	NULL
and	NULL
M-to-T	NULL
substitution	NULL
at	NULL
residue	NULL
407	NULL
)	NULL
and	NULL
that	NULL
partially	NULL
lack	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
truncation	NULL
at	NULL
residue	NULL
418	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
D.	NULL
Trono	NULL
(	NULL
University	NULL
of	NULL
Geneva	NULL
,	NULL
Geneva	NULL
,	NULL
Switzerland	NULL
)	NULL
.	NULL

Other	NULL
CD4	NULL
mutants	NULL
that	NULL
disrupt	NULL
the	NULL
association	NULL
with	NULL
p56**	NULL
(	NULL
CC-to-AA	NULL
substitution	NULL
in	NULL
the	NULL
dicysteine	NULL
motif	NULL
at	NULL
residues	NULL
420	NULL
and	NULL
422	NULL
)	NULL
or	NULL
lack	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
truncation	NULL
at	NULL
residue	NULL
402	NULL
)	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
CD4	NULL
sequences	NULL
were	NULL
subsequently	NULL
cloned	NULL
as	NULL
Xhol-BemHI	NULL
fragments	NULL
in	NULL
the	NULL
retroviral	NULL
expression	NULL
vector	NULL
pLPONL	NULL
(	NULL
76	NULL
)	NULL
and	NULL
were	NULL
transfected	NULL
in	NULL
the	NULL
packaging	NULL
cell	NULL
line	NULL
293GP	NULL
(	NULL
Viagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
by	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
.	NULL

293GP	NULL
cells	NULL
were	NULL
selected	NULL
for	NULL
neomycin	NULL
resistance	NULL
with	NULL
G418	NULL
(	NULL
500	NULL
pg/m1	NULL
)	NULL
,	NULL
and	NULL
the	NULL
resistant	NULL
population	NULL
was	NULL
used	NULL
to	NULL
generate	NULL
pscudotyped	NULL
virus	NULL
.	NULL

293GP	NULL
clones	NULL
were	NULL
transfected	NULL
with	NULL
20	NULL
pg	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
vesicular	NULL
stomatitis	NULL
virus	NULL
protein	NULL
(	NULL
pHCMV-G	NULL
)	NULL
by	NULL
calcium	NULL
phosphate	NULL
coprecipitation	NULL
.	NULL

The	NULL
pseudo-typed	NULL
virions	NULL
were	NULL
collected	NULL
72	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Culture	NULL
supernatants	NULL
were	NULL
filtered	NULL
and	NULL
used	NULL
to	NULL
infect	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
,	NULL
obtained	NULL
from	NULL
Rafick-Pierre	NULL
Sekaly	NULL
(	NULL
Institut	NULL
de	NULL
Recherches	NULL
Cliniques	NULL
de	NULL
Montréal	NULL
,	NULL
Montréal	NULL
,	NULL
Canada	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Polybrene	NULL
(	NULL
8	NULL
pg/ml	NULL
)	NULL
.	NULL

Resistant	NULL
A2.01	NULL
cell	NULL
populations	NULL
were	NULL
selected	NULL
for	NULL
each	NULL
of	NULL
the	NULL
constructs	NULL
,	NULL
and	NULL
cells	NULL
expressing	NULL
CD4	NULL
on	NULL
their	NULL
surface	NULL
were	NULL
sorted	NULL
under	NULL
sterile	NULL
conditions	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
(	NULL
with	NULL
the	NULL
MAb	NULL
OKT-4	NULL
)	NULL
.	NULL

For	NULL
each	NULL
cell	NULL
line	NULL
,	NULL
we	NULL
used	NULL
flow	NULL
cytometry	NULL
to	NULL
select	NULL
bulk	NULL
populations	NULL
expressing	NULL
comparable	NULL
levels	NULL
of	NULL
CD4	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
by	NULL
using	NULL
Quantum	NULL
Simply	NULL
Cellular	NULL
microbeads	NULL
(	NULL
Flow	NULL
Cytometry	NULL
Standards	NULL
Corp.	NULL
,	NULL
San	NULL
Juan	NULL
,	NULL
P.R	NULL
.	NULL
)	NULL

and	NULL
the	NULL
MAb	NULL
OKT-4	NULL
conjugated	NULL
to	NULL
FITC	NULL
.	NULL

Wild-type	NULL
and	NULL
mutated	NULL
CD4	NULL
cell	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gibco-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
Md	NULL
.	NULL
)	NULL

supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
.	NULL

The	NULL
stable	NULL
transfected	NULL
cells	NULL
were	NULL
maintained	NULL
under	NULL
G418	NULL
(	NULL
500	NULL
ug/m	NULL
!	NULL
)	NULL

selection	NULL
.	NULL

Virus	NULL
preparation	NULL
,	NULL
in	NULL
vitro	NULL
HIV-1	NULL
infection	NULL
,	NULL
and	NULL
p24	NULL
ELISA	NULL
.	NULL

High-titer	NULL
stocks	NULL
of	NULL
HIV-1	NULL
;	NULL
a	NULL
;	NULL
(	NULL
2.5	NULL
X	NULL
10°	NULL
50	NULL
%	NULL
tissue	NULL
culture	NULL
infective	NULL
doses	NULL
[	NULL
TCID	NULL
]	NULL
s	NULL
,	NULL
/m	NULL
!	NULL
)	NULL

were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
titer	NULL
determination	NULL
by	NULL
end-point	NULL
dilution	NULL
(	NULL
44	NULL
)	NULL
.	NULL

High	NULL
titer	NULL
stocks	NULL
were	NULL
prepared	NULL
by	NULL
inoculating	NULL
CEM	NULL
cells	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
(	NULL
moi	NULL
)	NULL
of	NULL
0.001	NULL
TCIDs	NULL
,	NULL
/m	NULL
!	NULL

l	NULL
and	NULL
growing	NULL
the	NULL
cells	NULL
for	NULL
10	NULL
days	NULL
.	NULL

A	NULL
10-ml	NULL
volume	NULL
of	NULL
culture	NULL
was	NULL
added	NULL
to	NULL
400	NULL
ml	NULL
of	NULL
uninfected	NULL
CEM	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
and	NULL
grown	NULL
for	NULL
5	NULL
to	NULL
7	NULL
days	NULL
until	NULL
abundant	NULL
syncytia	NULL
were	NULL
present	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
pelleted	NULL
(	NULL
300	NULL
%	NULL
g	NULL
for	NULL
10	NULL
min	NULL
)	NULL
and	NULL
resuspended	NULL
in	NULL
1/100	NULL
of	NULL
the	NULL
initial	NULL
volume	NULL
for	NULL
8	NULL
h.	NULL
The	NULL
supernatant	NULL
was	NULL
clarified	NULL
by	NULL
centrifugation	NULL
(	NULL
800	NULL
X	NULL
g	NULL
for	NULL
10	NULL
min	NULL
)	NULL
.	NULL

The	NULL
infection	NULL
protocol	NULL
was	NULL
identical	NULL
for	NULL
each	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
.	NULL

Cells	NULL
were	NULL
passaged	NULL
the	NULL
day	NULL
before	NULL
infection	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
G418	NULL
selection	NULL
.	NULL

Briefly	NULL
,	NULL
5	NULL
10°	NULL
to	NULL
10	NULL
x	NULL
10°	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HIV-1y	NULL
a	NULL
;	NULL
at	NULL
a	NULL
moi	NULL
of	NULL
0.1	NULL
.	NULL

After	NULL
a	NULL
2-h	NULL
inoculation	NULL
period	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
air	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
to	NULL
remove	NULL
inoculum	NULL
virus	NULL
and	NULL
resuspended	NULL
at	NULL
a	NULL
density	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

CD4*	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
as	NULL
described	NULL
by	NULL
Spina	NULL
et	NULL
al	NULL
.	NULL

(	NULL
61	NULL
)	NULL
.	NULL

Purified	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
fresh	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
[	NULL
vol/vol	NULL
]	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
2	NULL
mM	NULL
J.	NULL
ViRoL	NULL
.	NULL

glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
and	NULL
streptomycin	NULL
)	NULL
containing	NULL
recombinant	NULL
interleukin-2	NULL
(	NULL
rIL-2	NULL
)	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
40	NULL
U/ml	NULL
;	NULL
DuPont-New	NULL
England	NULL
Nuclear	NULL
Research	NULL
Products	NULL
,	NULL
Boston	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

and	NULL
stimulated	NULL
with	NULL
phytohemagglutinin	NULL
(	NULL
3	NULL
pg/ml	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

After	NULL
72	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
a	NULL
;	NULL
at	NULL
a	NULL
MOI	NULL
of	NULL
0.1	NULL
.	NULL

After	NULL
a	NULL
2-h	NULL
inoculation	NULL
period	NULL
at	NULL
37°C	NULL
in	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
air	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
PBS	NULL
to	NULL
remove	NULL
inoculum	NULL
virus	NULL
and	NULL
resuspended	NULL
at	NULL
a	NULL
density	NULL
of	NULL
10°	NULL
cells/ml	NULL
in	NULL
fresh	NULL
medium	NULL
containing	NULL
rIL-2	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
40	NULL
U/ml	NULL
)	NULL
.	NULL

HIV-1	NULL
p24	NULL
antigen	NULL
was	NULL
measured	NULL
by	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
as	NULL
described	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
Coulter	NULL
Corp.	NULL
,	NULL
Miami	NULL
,	NULL
Fla.	NULL
)	NULL
.	NULL

Assays	NULL
for	NULL
apoptosis	NULL
.	NULL

(	NULL
i	NULL
)	NULL
DNA	NULL
fragmentation	NULL
and	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

Cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
30	NULL
%	NULL
ethanol	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
kept	NULL
at	NULL
4°C	NULL
until	NULL
analyzed	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
for	NULL
DNA	NULL
content	NULL
analysis	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
23	NULL
,	NULL
66	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
Fluorochrome-labeled	NULL
annexin-V	NULL
binding	NULL
.	NULL

Phosphatidylserine	NULL
on	NULL
the	NULL
outer	NULL
lamella	NULL
of	NULL
apoptotic	NULL
cell	NULL
membranes	NULL
was	NULL
detected	NULL
with	NULL
FITC-conjugated	NULL
annexin-V	NULL
(	NULL
R	NULL
&	NULL
D	NULL
System	NULL
,	NULL
Minneapolis	NULL
,	NULL
Minn.	NULL
)	NULL
.	NULL

Differentiation	NULL
from	NULL
necrotic	NULL
cells	NULL
was	NULL
performed	NULL
with	NULL
7-AAD	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Light	NULL
microscopy	NULL
.	NULL

Cells	NULL
displaying	NULL
characteristic	NULL
condensation	NULL
and	NULL
fragmentation	NULL
of	NULL
nuclear	NULL
chromatin	NULL
and	NULL
permeable	NULL
to	NULL
trypan	NULL
blue	NULL
were	NULL
counted	NULL
as	NULL
apoptotic	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Quantification	NULL
of	NULL
surface	NULL
CD4	NULL
receptor	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Uninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
(	NULL
10°	NULL
)	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
PBS	NULL
with	NULL
2	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

The	NULL
fluorescein-conjugated	NULL
anti-CD4	NULL
MAb	NULL
OKT-4	NULL
was	NULL
added	NULL
(	NULL
20	NULL
pl	NULL
)	NULL
to	NULL
the	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
then	NULL
kept	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
for	NULL
staining	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
500	NULL
pl	NULL
of	NULL
1	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
kept	NULL
in	NULL
the	NULL
dark	NULL
at	NULL
4°C	NULL
until	NULL
analyzed	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
.	NULL

CD4	NULL
cell	NULL
surface	NULL
expression	NULL
was	NULL
quantified	NULL
with	NULL
Quantum	NULL
Simply	NULL
Cellular	NULL
microbeads	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
Elite	NULL
;	NULL
Coulter	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
.	NULL

Cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
(	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
were	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
on	NULL
ice	NULL
with	NULL
500	NULL
l	NULL
of	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
[	NULL
NP-40	NULL
]	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
20	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
pyrophosphate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
protease	NULL
inhibitors	NULL
(	NULL
10	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
)	NULL
and	NULL
the	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
sodium	NULL
orthovanadate	NULL
at	NULL
1	NULL
mM	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
their	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
a	NULL
Bradford	NULL
assay	NULL
.	NULL

For	NULL
immuno-precipitations	NULL
,	NULL
1-mg	NULL
protein	NULL
aliquots	NULL
of	NULL
lysates	NULL
were	NULL
precleared	NULL
with	NULL
protein	NULL
G-Sepharose	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
mouse	NULL
IgG1	NULL
OKT-4	NULL
MAb	NULL
coupled	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
the	NULL
following	NULL
buffers	NULL
.	NULL

Buffer	NULL
1	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
)	NULL
,	NULL
buffer	NULL
2	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
)	NULL
,	NULL
and	NULL
buffer	NULL
3	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
500	NULL
mM	NULL
NaCl	NULL
)	NULL
.	NULL

They	NULL
were	NULL
denatured	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
%	NULL
nonreducing	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
.	NULL

Denatured	NULL
samples	NULL
were	NULL
resolved	NULL
by	NULL
SDS-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blocked	NULL
in	NULL
SuperBlock	NULL
blocking	NULL
buffer	NULL
in	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
;	NULL
Pierce	NULL
,	NULL
Rockford	NULL
,	NULL
IIL	NULL
.	NULL
)	NULL

for	NULL
45	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
CD4-associ-ated	NULL
p56**	NULL
was	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
rabbit	NULL
antiserum	NULL
against	NULL
Ick	NULL
as	NULL
the	NULL
primary	NULL
antibody	NULL
followed	NULL
by	NULL
peroxidase-labeled	NULL
anti-rabbit	NULL
IgG	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
developed	NULL
by	NULL
using	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Inc.	NULL
,	NULL
Cleveland	NULL
,	NULL
Ohio	NULL
)	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Cross-linking	NULL
,	NULL
antiphosphotyrosine	NULL
immunoblots	NULL
,	NULL
and	NULL
kinase	NULL
assays	NULL
of	NULL
pS	NULL
Antibody-mediated	NULL
cross-linking	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
75	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
centrifuged	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
250	NULL
pl	NULL
of	NULL
the	NULL
appropriate	NULL
MAb	NULL
at	NULL
saturating	NULL
concentration	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
resuspended	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
medium	NULL
without	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
and	NULL
transferred	NULL
to	NULL
an	NULL
Eppendorf	NULL
tube	NULL
.	NULL

After	NULL
3	NULL
min	NULL
at	NULL
37°C	NULL
,	NULL
2	NULL
g	NULL
of	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Fab	NULL
'	NULL
)	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
and	NULL
the	NULL
mixture	NULL
was	NULL
incubated	NULL
for	NULL
2	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
ice-cold	NULL
PBS	NULL
and	NULL
lysed	NULL
on	NULL
ice	NULL
with	NULL
200	NULL
pl	NULL
of	NULL
lysis	NULL
buffer	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
their	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
assay	NULL
.	NULL

For	NULL
antiphosphotyrosine	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
denatured	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2	NULL
%	NULL
nonreducing	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

Denatured	NULL
samples	NULL
were	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
transferred	NULL
to	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
.	NULL

Proteins	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
residues	NULL
were	NULL
detected	NULL
by	NULL
immunoblotting	NULL
with	NULL
MAb	NULL
4G10	NULL
followed	NULL
by	NULL
peroxidase-coupled	NULL
polyclonal	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
developed	NULL
by	NULL
the	NULL
enhanced	NULL
chemiluminescence	NULL
method	NULL
.	NULL

For	NULL
the	NULL
kinase	NULL
assay	NULL
,	NULL
the	NULL
lysates	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
rabbit	NULL
anti-lck	NULL
coupled	NULL
to	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS-0.5	NULL
%	NULL
NP-40	NULL
,	NULL
once	NULL
with	NULL
0.5	NULL
M	NULL
LiCl-50	NULL
mM	NULL
Tris	NULL
HCI	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
and	NULL
once	NULL
with	NULL
distilled	NULL
H	NULL
,	NULL
O	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
then	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
min	NULL
in	NULL
30	NULL
pl	NULL
of	NULL
kinase	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris	NULL
HCI	NULL
[	NULL
pH	NULL
7.4	NULL
]	NULL
,	NULL
10	NULL
mm	NULL
MnCl	NULL
,	NULL
)	NULL
containing	NULL
10	NULL
wCi	NULL
of	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
before	NULL
being	NULL
washed	NULL
in	NULL
distilled	NULL
H	NULL
,	NULL
O	NULL
and	NULL
analyzed	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
autoradiography	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
EMSAs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
54	NULL
)	NULL
.	NULL

The	NULL
pellet	NULL
(	NULL
5	NULL
x	NULL
10°	NULL
to	NULL
1	NULL
x	NULL
10	NULL
``	NULL
cells	NULL
)	NULL
was	NULL
washed	NULL
once	NULL
in	NULL
ice-cold	NULL
PBS	NULL
,	NULL
resuspended	NULL
with	NULL
5	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
1	NULL
mM	NULL
phenymethylsulfonyl	NULL
fluoride	NULL
)	NULL
,	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
2.5	NULL
pl	NULL
of	NULL
5	NULL
%	NULL
NP-40	NULL
,	NULL
and	NULL
lysis	NULL
was	NULL
microscopically	NULL
monitored	NULL
by	NULL
61:1	NULL
:	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
trypan	NULL
blue	NULL
staining	NULL
.	NULL

Nuclei	NULL
were	NULL
pelleted	NULL
at	NULL
1,200	NULL
x	NULL
g	NULL
for	NULL
1	NULL
min	NULL
,	NULL
washed	NULL
once	NULL
in	NULL
5	NULL
volumes	NULL
of	NULL
buffer	NULL
A	NULL
,	NULL
and	NULL
resuspended	NULL
in	NULL
200	NULL
pl	NULL
of	NULL
buffer	NULL
B	NULL
(	NULL
250	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.8	NULL
]	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
.	NULL

After	NULL
the	NULL
nuclei	NULL
had	NULL
been	NULL
transferred	NULL
to	NULL
Eppendorf	NULL
tubes	NULL
,	NULL
three	NULL
freeze-thaw	NULL
cycles	NULL
were	NULL
performed	NULL
with	NULL
dry	NULL
ice	NULL
and	NULL
a	NULL
37°C	NULL
water	NULL
bath	NULL
.	NULL

Nuclei	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
x	NULL
g	NULL
for	NULL
15	NULL
min	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
of	NULL
the	NULL
supernatant	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
micro-Bradford	NULL
assay	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
used	NULL
.	NULL

The	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
2	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
100	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
500	NULL
mM	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
10	NULL
mm	NULL
EDTA	NULL
,	NULL
50	NULL
%	NULL
glycerol	NULL
)	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
2	NULL
pl	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
(	NULL
0.25	NULL
mg/ml	NULL
)	NULL
,	NULL
10	NULL
mg	NULL
of	NULL
protein	NULL
extract	NULL
(	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
Oct-1	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
[	NULL
EMSA	NULL
]	NULL
)	NULL
,	NULL
and	NULL
2	NULL
pl	NULL
of	NULL
radioactively	NULL
labeled	NULL
DNA	NULL
probe	NULL
(	NULL
10,000	NULL
cpm/pl	NULL
)	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
,	NULL
the	NULL
reaction	NULL
products	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

In	NULL
competition	NULL
experiments	NULL
,	NULL
unlabeled	NULL
probes	NULL
were	NULL
added	NULL
in	NULL
excess	NULL
to	NULL
the	NULL
reaction	NULL
mixture	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
*°P-labelled	NULL
probes	NULL
.	NULL

RNA	NULL
isolation	NULL
and	NULL
RT-PCR	NULL
amplification	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
with	NULL
the	NULL
RNeasy	NULL
total	NULL
RNA	NULL
kit	NULL
(	NULL
Qiagen	NULL
Inc.	NULL
,	NULL
Chatsworth	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

RNA	NULL
samples	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
were	NULL
then	NULL
mixed	NULL
with	NULL
300	NULL
ng	NULL
of	NULL
oligonucleotide	NULL
(	NULL
dTO15	NULL
primer	NULL
[	NULL
Promega	NULL
]	NULL
)	NULL
,	NULL
heated	NULL
at	NULL
65°C	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
cooled	NULL
on	NULL
ice	NULL
.	NULL

First-strand	NULL
cDNA	NULL
synthesis	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
37°C	NULL
for	NULL
1	NULL
h	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
50	NULL
pl	NULL
containing	NULL
50	NULL
mM	NULL
Tris	NULL
HCl	NULL
(	NULL
pH	NULL
8.3	NULL
)	NULL
,	NULL
75	NULL
mM	NULL
KCl	NULL
,	NULL
3	NULL
mM	NULL
MgCl	NULL
,	NULL
10	NULL
mM	NULL
DTT	NULL
,	NULL
4	NULL
mM	NULL
deoxynucleoside	NULL
triphosphates	NULL
,	NULL
10	NULL
U	NULL
of	NULL
RNase	NULL
inhibitor	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
and	NULL
50	NULL
U	NULL
of	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
(	NULL
RT	NULL
)	NULL
(	NULL
Gibco-BRL	NULL
)	NULL
.	NULL

Each	NULL
cDNA	NULL
mixture	NULL
(	NULL
5	NULL
pl	NULL
)	NULL
was	NULL
subsequently	NULL
amplified	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
100	NULL
pl	NULL
containing	NULL
20	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.7	NULL
)	NULL
at	NULL
20°C	NULL
,	NULL
16	NULL
mM	NULL
(	NULL
NH	NULL
,	NULL
)	NULL
;	NULL
SO	NULL
,	NULL
,	NULL
2.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
200	NULL
mM	NULL
deoxynucleoside	NULL
triphosphates	NULL
,	NULL
700	NULL
ng	NULL
of	NULL
each	NULL
primer	NULL
,	NULL
and	NULL
2.5	NULL
U	NULL
of	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
(	NULL
Perkin-Elmer	NULL
)	NULL
.	NULL

Primer	NULL
sequences	NULL
for	NULL
the	NULL
Fas	NULL
ligand	NULL
5'-agotcttccacctgcagaag-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5'-cctcaaaattgaccagagagag-3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
were	NULL
designed	NULL
to	NULL
amplify	NULL
a	NULL
504-bp	NULL
product	NULL
.	NULL

Primer	NULL
sequences	NULL
for	NULL
B-actin	NULL
5'-ga	NULL
cgaggeccagagcaagagagg-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5'-gatccacatctgctggaaggtggac-3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
were	NULL
designed	NULL
to	NULL
amplify	NULL
a	NULL
350-bp	NULL
product	NULL
of	NULL
the	NULL
B-actin	NULL
transcript	NULL
and	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
RNA	NULL
extraction	NULL
.	NULL

Amplification	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
thermal	NULL
cycler	NULL
(	NULL
Perkin-Elmer	NULL
)	NULL
for	NULL
2	NULL
min	NULL
at	NULL
94°C	NULL
and	NULL
for	NULL
35	NULL
cycles	NULL
(	NULL
Fas	NULL
ligand	NULL
)	NULL
or	NULL
30	NULL
cycles	NULL
(	NULL
B-actin	NULL
)	NULL
as	NULL
follows	NULL
:	NULL
for	NULL
Fas	NULL
ligand	NULL
,	NULL
1	NULL
min	NULL
at	NULL
94°C	NULL
,	NULL
1	NULL
min	NULL
at	NULL
56°C	NULL
,	NULL
and	NULL
1.5	NULL
min	NULL
at	NULL
72°C	NULL
with	NULL
a	NULL
final	NULL
elongation	NULL
for	NULL
8.5	NULL
min	NULL
at	NULL
72°C	NULL
;	NULL
for	NULL
B-actin	NULL
,	NULL
15	NULL
s	NULL
at	NULL
94°C	NULL
and	NULL
1	NULL
min	NULL
at	NULL
68°C	NULL
with	NULL
a	NULL
final	NULL
elongation	NULL
for	NULL
10	NULL
min	NULL
at	NULL
72°C	NULL
.	NULL

RESULTS	NULL
The	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
,	NULL
independent	NULL
of	NULL
its	NULL
association	NULL
with	NULL
p56	NULL
,	NULL
is	NULL
a	NULL
determinant	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
during	NULL
acute	NULL
HIV	NULL
infection	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
CD4	NULL
transduction	NULL
pathway	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
CD4	NULL
wild-type	NULL
and	NULL
mutated	NULL
receptors	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
stably	NULL
expressed	NULL
in	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
,	NULL
which	NULL
does	NULL
not	NULL
express	NULL
CD4	NULL
.	NULL

The	NULL
mutations	NULL
included	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
association	NULL
of	NULL
CD4	NULL
and	NULL
p56*	NULL
``	NULL
*	NULL
(	NULL
AA	NULL
substitutions	NULL
in	NULL
the	NULL
dicysteine	NULL
motif	NULL
at	NULL
residues	NULL
420	NULL
and	NULL
422	NULL
)	NULL
or	NULL
interference	NULL
with	NULL
Nef-associated	NULL
motifs	NULL
(	NULL
AA	NULL
substitutions	NULL
in	NULL
the	NULL
dileucine	NULL
motif	NULL
at	NULL
residues	NULL
413	NULL
and	NULL
414	NULL
or	NULL
substitution	NULL
at	NULL
residue	NULL
407	NULL
)	NULL
(	NULL
1	NULL
,	NULL
41	NULL
,	NULL
60	NULL
)	NULL
and	NULL
partial	NULL
or	NULL
total	NULL
truncations	NULL
of	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
at	NULL
residues	NULL
418	NULL
and	NULL
402	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

These	NULL
variants	NULL
were	NULL
expressed	NULL
at	NULL
the	NULL
surface	NULL
of	NULL
A2.01	NULL
cells	NULL
at	NULL
comparable	NULL
levels	NULL
with	NULL
a	NULL
mean	NULL
density	NULL
of	NULL
40,000	NULL
to	NULL
50,000	NULL
CD4	NULL
receptors	NULL
per	NULL
cell	NULL
,	NULL
which	NULL
approximates	NULL
the	NULL
number	NULL
of	NULL
receptors	NULL
found	NULL
on	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
evaluated	NULL
in	NULL
these	NULL
cells	NULL
after	NULL
infection	NULL
with	NULL
HIV-1	NULL
;	NULL
/	NULL
;	NULL
at	NULL
a	NULL
MOI	NULL
of	NULL
0.1	NULL
TCIDs	NULL
,	NULL
/ml	NULL
.	NULL

The	NULL
level	NULL
of	NULL
viral	NULL
production	NULL
,	NULL
determined	NULL
by	NULL
ELISA	NULL
for	NULL
HIV	NULL
p24	NULL
antigen	NULL
,	NULL
was	NULL
comparable	NULL
for	NULL
each	NULL
of	NULL
the	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
assessed	NULL
by	NULL
several	NULL
methods	NULL
:	NULL
flow	NULL
cytometry	NULL
(	NULL
both	NULL
cell	NULL
cycle	NULL
analysis	NULL
and	NULL
fluorochrome	NULL
labeled	NULL
annexin-V	NULL
binding	NULL
)	NULL
,	NULL
fluorescent	NULL
DNA	NULL
dye	NULL
(	NULL
Hoechst	NULL
dye	NULL
uptake	NULL
)	NULL
,	NULL
and	NULL
light	NULL
microscopy	NULL
(	NULL
nuclear	NULL
condensation	NULL
and	NULL
fragmentation	NULL
)	NULL
.	NULL

These	NULL
different	NULL
techniques	NULL
provided	NULL
very	NULL
similar	NULL
percentages	NULL
of	NULL
apoptosis	NULL
.	NULL

Apoptosis	NULL
was	NULL
measured	NULL
after	NULL
HIV	NULL
infection	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
expressing	NULL
different	NULL
CD4	NULL
constructs	NULL
,	NULL
using	NULL
flow	NULL
cytometry	NULL
with	NULL
FITC-conjugated	NULL
annexin-V	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Cells	NULL
expressing	NULL
the	NULL
mutation	NULL
at	NULL
the	NULL
dileucine	NULL
motif	NULL
and	NULL
the	NULL
mutation	NULL
at	NULL
residue	NULL
407	NULL
underwent	NULL
apoptosis	NULL
like	NULL
those	NULL
expressing	NULL
the	NULL
wild-type	NULL
CD4	NULL
.	NULL

Higher	NULL
levels	NULL
of	NULL
apoptosis	NULL
were	NULL
consistently	NULL
observed	NULL
in	NULL
HIV-infected	NULL
cells	NULL
expressing	NULL
the	NULL
mu	NULL
MOLECULAR	NULL
ANALYSIS	NULL
OF	NULL
HIV-INDUCED	NULL
APOPTOSIS	NULL
-	NULL
8063	NULL
extracellular	NULL
cytoplasmic	NULL
Stop	NULL
402	NULL
CD4	NULL
receptor	NULL
407	NULL
Dileucine	NULL
413	NULL
motif	NULL
414	NULL
422	NULL
-	NULL
Dicysteine	NULL
mutant	NULL
Stop	NULL
418	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Schematic	NULL
representation	NULL
of	NULL
CD4	NULL
and	NULL
the	NULL
mutants	NULL
investigated	NULL
in	NULL
this	NULL
study	NULL
.	NULL

The	NULL
CC-to-AA	NULL
substitution	NULL
in	NULL
the	NULL
dicysteine	NULL
motif	NULL
420	NULL
and	NULL
422	NULL
disrupts	NULL
€D4-p56	NULL
``	NULL
**	NULL
association	NULL
,	NULL
the	NULL
LL-to-AA	NULL
substitution	NULL
in	NULL
the	NULL
dileucine	NULL
motif	NULL
413	NULL
and	NULL
414	NULL
and	NULL
the	NULL
M-to-T	NULL
mutation	NULL
at	NULL
residue	NULL
407	NULL
interfere	NULL
with	NULL
Nef-associated	NULL
motifs	NULL
,	NULL
and	NULL
the	NULL
truncations	NULL
at	NULL
amino	NULL
acid	NULL
residues	NULL
418	NULL
and	NULL
402	NULL
respectively	NULL
(	NULL
418	NULL
Stop	NULL
and	NULL
402	NULL
Stop	NULL
)	NULL
partially	NULL
or	NULL
totally	NULL
delete	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

These	NULL
constructs	NULL
were	NULL
stably	NULL
expressed	NULL
in	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
.	NULL

tation	NULL
at	NULL
residue	NULL
407	NULL
.	NULL

Cell	NULL
death	NULL
was	NULL
also	NULL
observed	NULL
after	NULL
infection	NULL
of	NULL
cells	NULL
expressing	NULL
the	NULL
mutation	NULL
at	NULL
the	NULL
dicysteine	NULL
motif	NULL
,	NULL
which	NULL
does	NULL
not	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
.	NULL

This	NULL
demonstrated	NULL
the	NULL
ability	NULL
of	NULL
HIV	NULL
to	NULL
induce	NULL
apoptosis	NULL
when	NULL
CD4-p56	NULL
``	NULL
**	NULL
association	NULL
was	NULL
disrupted	NULL
.	NULL

This	NULL
was	NULL
further	NULL
confirmed	NULL
with	NULL
the	NULL
CD4	NULL
construct	NULL
truncated	NULL
in	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
at	NULL
residue	NULL
418	NULL
.	NULL

This	NULL
mutant	NULL
could	NULL
be	NULL
expressed	NULL
only	NULL
with	NULL
a	NULL
lower	NULL
mean	NULL
intensity	NULL
of	NULL
fluorescence	NULL
compared	NULL
to	NULL
the	NULL
CD4	NULL
mutant	NULL
truncated	NULL
at	NULL
residue	NULL
402	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
;	NULL
however	NULL
,	NULL
cells	NULL
expressing	NULL
this	NULL
truncated	NULL
mutant	NULL
receptor	NULL
displayed	NULL
comparable	NULL
levels	NULL
of	NULL
apoptosis	NULL
to	NULL
those	NULL
expressing	NULL
the	NULL
wild-type	NULL
CD4	NULL
(	NULL
21.4	NULL
%	NULL
on	NULL
day	NULL
4	NULL
after	NULL
infection	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Despite	NULL
similar	NULL
levels	NULL
of	NULL
viral	NULL
production	NULL
,	NULL
apoptosis	NULL
was	NULL
abrogated	NULL
in	NULL
infected	NULL
cells	NULL
expressing	NULL
the	NULL
mutant	NULL
truncated	NULL
at	NULL
residue	NULL
402	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
CD4-p56	NULL
``	NULL
association	NULL
is	NULL
dispensable	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
and	NULL
that	NULL
the	NULL
first	NULL
18	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
are	NULL
sufficient	NULL
to	NULL
mediate	NULL
the	NULL
process	NULL
.	NULL

Cell	NULL
cycle	NULL
analysis	NULL
and	NULL
DNA	NULL
profiles	NULL
confirmed	NULL
that	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
and	NULL
constructs	NULL
with	NULL
mutations	NULL
at	NULL
residue	NULL
407	NULL
,	NULL
the	NULL
dileucine	NULL
motif	NULL
,	NULL
and	NULL
the	NULL
dicysteine	NULL
motif	NULL
,	NULL
all	NULL
underwent	NULL
apoptosis	NULL
while	NULL
those	NULL
expressing	NULL
a	NULL
truncation	NULL
at	NULL
residue	NULL
402	NULL
displayed	NULL
little	NULL
apoptosis	NULL
during	NULL
HIV	NULL
infection	NULL
.	NULL

DNA	NULL
profiles	NULL
consistently	NULL
showed	NULL
a	NULL
diminution	NULL
of	NULL
the	NULL
proportion	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
a	NULL
concomittant	NULL
increase	NULL
in	NULL
the	NULL
fraction	NULL
of	NULL
cells	NULL
in	NULL
G/M	NULL
,	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
sub-G	NULL
,	NULL
DNA	NULL
content	NULL
,	NULL
representing	NULL
apoptotic	NULL
cells	NULL
.	NULL

The	NULL
DNA	NULL
profile	NULL
of	NULL
the	NULL
cells	NULL
expressing	NULL
the	NULL
mutant	NULL
truncated	NULL
at	NULL
residue	NULL
402	NULL
showed	NULL
a	NULL
constant	NULL
and	NULL
specific	NULL
accumulation	NULL
of	NULL
aneuploid	NULL
cells	NULL
upon	NULL
HIV	NULL
infection	NULL
but	NULL
no	NULL
apoptotic	NULL
cells	NULL
(	NULL
sub-G	NULL
,	NULL
DNA	NULL
)	NULL
during	NULL
the	NULL
4	NULL
days	NULL
of	NULL
observation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

HIV-induced	NULL
apoptosis	NULL
is	NULL
independent	NULL
of	NULL
NF-KB	NULL
transacti-vation	NULL
.	NULL

NF-kB	NULL
may	NULL
either	NULL
protect	NULL
from	NULL
or	NULL
promote	NULL
apoptosis	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
34	NULL
,	NULL
52	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
cells	NULL
expressing	NULL
distinct	NULL
forms	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
,	NULL
with	NULL
their	NULL
associated	NULL
differential	NULL
susceptibility	NULL
to	NULL
undergo	NULL
apoptosis	NULL
during	NULL
HIV	NULL
infection	NULL
,	NULL
differed	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

NF-kB	NULL
activity	NULL
in	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
A2.01	NULL
cells	NULL
expressing	NULL
wild-type	NULL
and	NULL
truncated	NULL
8064	NULL
MOUTOUH	NULL
ET	NULL
AL	NULL
.	NULL

meres	NULL
c	NULL
--	NULL
reap	NULL
J.	NULL
ViRoL	NULL
.	NULL

relative	NULL
cell	NULL
number	NULL
log	NULL
fluorescence	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Cell	NULL
surface	NULL
expression	NULL
of	NULL
CD4	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutants	NULL
stably	NULL
expressed	NULL
in	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
.	NULL

Surface	NULL
levels	NULL
of	NULL
CD4	NULL
were	NULL
evaluated	NULL
by	NULL
flow	NULL
cytometry	NULL
after	NULL
staining	NULL
with	NULL
FITC-labelled	NULL
OKT-4	NULL
anti-CD4	NULL
antibody	NULL
.	NULL

The	NULL
abscissa	NULL
gives	NULL
the	NULL
relative	NULL
fluorescence	NULL
intensity	NULL
on	NULL
a	NULL
logarithmic	NULL
scale	NULL
.	NULL

The	NULL
mutant	NULL
truncated	NULL
at	NULL
residue	NULL
418	NULL
was	NULL
generated	NULL
later	NULL
,	NULL
and	NULL
the	NULL
flow	NULL
cytometry	NULL
profile	NULL
corresponds	NULL
to	NULL
an	NULL
independent	NULL
analysis	NULL
.	NULL

dil	NULL
,	NULL
dileucine	NULL
;	NULL
diC	NULL
,	NULL
dicystcine	NULL
.	NULL

CD4	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
apoptotic	NULL
phenotype	NULL
in	NULL
HIV-infected	NULL
cells	NULL
was	NULL
related	NULL
to	NULL
different	NULL
degrees	NULL
of	NULL
NF-kB	NULL
activation	NULL
,	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
analyzed	NULL
before	NULL
infection	NULL
and	NULL
3	NULL
days	NULL
after	NULL
infection	NULL
(	NULL
when	NULL
cells	NULL
were	NULL
undergoing	NULL
apoptosis	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
were	NULL
analyzed	NULL
with	NULL
a	NULL
°°P	NULL
-labeled	NULL
DNA	NULL
probe	NULL
encompassing	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Basal	NULL
levels	NULL
of	NULL
NF-xB	NULL
activity	NULL
were	NULL
detectable	NULL
in	NULL
wild-type	NULL
and	NULL
mutated	NULL
CD4	NULL
cells	NULL
.	NULL

Three	NULL
days	NULL
after	NULL
infection	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
was	NULL
diminished	NULL
in	NULL
infected	NULL
cells	NULL
compared	NULL
to	NULL
uninfected	NULL
cells	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
they	NULL
expressed	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
activity	NULL
was	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
,	NULL
and	NULL
ratios	NULL
were	NULL
obtained	NULL
by	NULL
normalizing	NULL
to	NULL
the	NULL
level	NULL
of	NULL
endogenous	NULL
Oct-1	NULL
activity	NULL
.	NULL

The	NULL
ratios	NULL
confirmed	NULL
the	NULL
general	NULL
decrease	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
independently	NULL
of	NULL
their	NULL
apoptotic	NULL
phenotype	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
the	NULL
ubiquitous	NULL
factor	NULL
Oct-1	NULL
,	NULL
used	NULL
as	NULL
input	NULL
control	NULL
,	NULL
was	NULL
similar	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
and	NULL
mutant	NULL
CD4	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
binding	NULL
was	NULL
confirmed	NULL
by	NULL
a	NULL
competition	NULL
assay	NULL
performed	NULL
with	NULL
a	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-KB	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
propensity	NULL
of	NULL
cells	NULL
expressing	NULL
wild-type	NULL
and	NULL
mutated	NULL
CD4	NULL
to	NULL
undergo	NULL
apoptosis	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
any	NULL
distinctive	NULL
modification	NULL
in	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

The	NULL
apoptotic	NULL
outcome	NULL
was	NULL
neither	NULL
predetermined	NULL
by	NULL
initial	NULL
level	NULL
of	NULL
NF-KB	NULL
activity	NULL
nor	NULL
related	NULL
to	NULL
a	NULL
specific	NULL
level	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
during	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
NF-B	NULL
activity	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
during	NULL
HIV	NULL
infection	NULL
of	NULL
the	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
.	NULL

The	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
critical	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
independent	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
signaling	NULL
.	NULL

The	NULL
reduced	NULL
levels	NULL
of	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
in	NULL
cells	NULL
expressing	NULL
a	NULL
truncated	NULL
CD4	NULL
molecule	NULL
indicated	NULL
that	NULL
HIV	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
may	NULL
activate	NULL
a	NULL
signal	NULL
transduction	NULL
pathway	NULL
leading	NULL
to	NULL
apoptosis	NULL
.	NULL

To	NULL
further	NULL
characterize	NULL
the	NULL
signal	NULL
mediated	NULL
through	NULL
the	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
A	NULL
10°s	NULL
--	NULL
Vector	NULL
-*-	NULL
CD4wt	NULL
-a-	NULL
M407T	NULL
10	NULL
%	NULL
--	NULL
dil	NULL
-=-	NULL
diC	NULL
-*-	NULL
402	NULL
stop	NULL
-x-	NULL
418	NULL
stop	NULL
10°	NULL
10	NULL
``	NULL
p24	NULL
(	NULL
ng/ml	NULL
)	NULL
10	NULL
1	NULL
1	NULL
1	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Days	NULL
after	NULL
infection	NULL
30	NULL
;	NULL
-	NULL
[	NULL
]	NULL
Vector	NULL
m	NULL
-	NULL
25	NULL
-	NULL
WR	NULL
CD4wt	NULL
é	NULL
J	NULL
M4O7T	NULL
o	NULL
-	NULL
zo	NULL
|-	NULL
BR	NULL
dil	NULL
O	NULL
©	NULL
dC	NULL
7	NULL
o	NULL
|_	NULL
402	NULL
stop	NULL
2	NULL
o	NULL
--	NULL
15	NULL
4	NULL
33	NULL
A	NULL
418	NULL
stop	NULL
Z	NULL
§	NULL
do	NULL
}	NULL
A	NULL
2	NULL
.	NULL

2	NULL
a	NULL
7	NULL
<	NULL
4	NULL
5	NULL
|-	NULL
&	NULL
g	NULL
o	NULL
f	NULL
g	NULL
0	NULL
1	NULL
|	NULL
'	NULL
B	NULL
1	NULL
``	NULL
8	NULL
1	NULL
A	NULL
0	NULL
3	NULL
4	NULL
Days	NULL
after	NULL
infection	NULL
he	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Apoptosis	NULL
in	NULL
CD4	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Virus	NULL
production	NULL
assessed	NULL
by	NULL
p24	NULL
antigen	NULL
ELISA	NULL
in	NULL
CD4	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
and	NULL
mutants	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
(	NULL
MOL	NULL
,	NULL
0.1	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Apoptosis	NULL
assessed	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
fluorochrome-labelled	NULL
annexin-V	NULL
binding	NULL
)	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
mutant	NULL
truncated	NULL
at	NULL
residue	NULL
418	NULL
was	NULL
generated	NULL
later	NULL
,	NULL
and	NULL
the	NULL
results	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

dil	NULL
,	NULL
dileucine	NULL
;	NULL
diC	NULL
,	NULL
dicysteine	NULL
.	NULL

CD4	NULL
cytoplasmic	NULL
tail	NULL
and	NULL
determine	NULL
whether	NULL
p56	NULL
``	NULL
**	NULL
signaling	NULL
may	NULL
be	NULL
involved	NULL
despite	NULL
the	NULL
disruption	NULL
of	NULL
association	NULL
(	NULL
18	NULL
)	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
patterns	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
tyrosine	NULL
kinase	NULL
activity	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
upon	NULL
CD4	NULL
stimulation	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
and	NULL
variants	NULL
of	NULL
CD4	NULL
mutated	NULL
to	NULL
not	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
.	NULL

The	NULL
association	NULL
of	NULL
CD4	NULL
with	NULL
p56**	NULL
was	NULL
comparable	NULL
in	NULL
A2.01	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
and	NULL
in	NULL
those	NULL
expressing	NULL
CD4	NULL
mutated	NULL
at	NULL
the	NULL
dileucine	NULL
motif	NULL
and	NULL
residue	NULL
407	NULL
(	NULL
Fig	NULL
.	NULL

SA	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
p56	NULL
did	NULL
not	NULL
coimmunoprecipitate	NULL
with	NULL
CD4	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
dicysteine	NULL
or	NULL
truncated	NULL
mutants	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
wild-type	NULL
CD4	NULL
.	NULL

All	NULL
these	NULL
forms	NULL
of	NULL
CD4	NULL
were	NULL
cross-linked	NULL
with	NULL
OKT-4	NULL
MAb	NULL
,	NULL
which	NULL
recognizes	NULL
an	NULL
epitope	NULL
in	NULL
extracellular	NULL
domain	NULL
4	NULL
of	NULL
the	NULL
MOLECULAR	NULL
ANALYSIS	NULL
OF	NULL
HIV-INDUCED	NULL
APOPTOSIS	NULL
-	NULL
8065	NULL
CD4	NULL
receptor	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
after	NULL
stimulation	NULL
with	NULL
OKT	NULL
-4	NULL
MAb	NULL
was	NULL
comparable	NULL
for	NULL
each	NULL
of	NULL
the	NULL
CD4	NULL
constructs	NULL
ScFig	NULL
.	NULL

5B	NULL
)	NULL
;	NULL
however	NULL
,	NULL
wild-type	NULL
CD4	NULL
,	NULL
which	NULL
associates	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
,	NULL
displayed	NULL
an	NULL
increased	NULL
in	NULL
p56*	NULL
``	NULL
*	NULL
phos-phorylation	NULL
.	NULL

Similar	NULL
patterns	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
were	NULL
observed	NULL
when	NULL
the	NULL
CD4	NULL
receptor	NULL
was	NULL
cross-linked	NULL
with	NULL
MAbs	NULL
that	NULL
recognize	NULL
different	NULL
epitopes	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
(	NULL
Leu3a	NULL
and	NULL
13B8-2	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

No	NULL
changes	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
were	NULL
observed	NULL
after	NULL
cross-linking	NULL
with	NULL
UV-psoralen-inactivated	NULL
HIV	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Wild-type	NULL
CD4	NULL
,	NULL
the	NULL
construct	NULL
with	NULL
the	NULL
mutation	NULL
at	NULL
the	NULL
dicysteine	NULL
resi-dues	NULL
,	NULL
and	NULL
constructs	NULL
truncated	NULL
at	NULL
residues	NULL
402	NULL
or	NULL
418	NULL
exhibited	NULL
different	NULL
patterns	NULL
of	NULL
p56	NULL
``	NULL
kinase	NULL
activity	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
CD4	NULL
with	NULL
OKT-4	NULL
MAb	NULL
led	NULL
to	NULL
a	NULL
rapid	NULL
and	NULL
potent	NULL
autophosphorylation	NULL
of	NULL
pS56**	NULL
in	NULL
wild-type	NULL
CD4	NULL
.	NULL

Mutated	NULL
receptors	NULL
that	NULL
do	NULL
not	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
presented	NULL
either	NULL
no	NULL
modification	NULL
(	NULL
402	NULL
truncated	NULL
mutant	NULL
)	NULL
or	NULL
abolition	NULL
(	NULL
dicysteine	NULL
and	NULL
418	NULL
truncated	NULL
mutants	NULL
)	NULL
of	NULL
initial	NULL
p56	NULL
``	NULL
**	NULL
kinase	NULL
activity	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
apoptotic	NULL
phe-	NULL
HIV-infected	NULL
cells	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
Uninfected	NULL
cells	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
#	NULL
%	NULL
-	NULL
L	NULL
o-ouuus	NULL
t	NULL
:	NULL
=-	NULL
NF-xB	NULL
ratio	NULL
22	NULL
1	NULL
13	NULL
3	NULL
0.5	NULL
0.8	NULL
0.7	NULL
0.5	NULL
0.8	NULL
0.7	NULL
0.8	NULL
wesstidtdadi	NULL
)	NULL
-	NULL
«	NULL
ons	NULL
bos	NULL
im	NULL
20	NULL
1.6	NULL
1.1	NULL
wl	NULL
tical	NULL
tatt	NULL
tical	NULL
*	NULL
tout	NULL
hou	NULL
i.	NULL
,	NULL
to	NULL
#	NULL
B	NULL
*p	NULL
oct-1	NULL
*P	NULL
NF-KB	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
m	NULL
u	NULL
--	NULL
Free	NULL
Probe	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

DNA-binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
during	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Effect	NULL
of	NULL
HIV-infection	NULL
on	NULL
NF-kB	NULL
activation	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
CD4	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
nuclear	NULL
extracts	NULL
(	NULL
10	NULL
g	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
and	NULL
analyzed	NULL
with	NULL
*°P-labeled	NULL
DNA	NULL
probes	NULL
encompassing	NULL
a	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
NF-B	NULL
and	NULL
the	NULL
ubiquitous	NULL
factor	NULL
Oct-1	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
uninfected	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
7	NULL
)	NULL
or	NULL
cells	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
for	NULL
3	NULL
days	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
14	NULL
)	NULL
expressing	NULL
CD4	NULL
wild	NULL
type	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
8	NULL
)	NULL
,	NULL
mutants	NULL
407	NULL
M	NULL
to	NULL
T	NULL
(	NULL
lane	NULL
2	NULL
and	NULL
9	NULL
)	NULL
,	NULL
dileucine	NULL
(	NULL
lane	NULL
3	NULL
and	NULL
10	NULL
)	NULL
,	NULL
dicysteine	NULL
(	NULL
lane	NULL
4	NULL
and	NULL
11	NULL
)	NULL
,	NULL
402	NULL
truncated	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
12	NULL
)	NULL
,	NULL
and	NULL
418	NULL
truncated	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
13	NULL
)	NULL
and	NULL
the	NULL
vector	NULL
control	NULL
(	NULL
lane	NULL
7	NULL
and	NULL
14	NULL
)	NULL
were	NULL
analyzed	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
transactivation	NULL
in	NULL
wild-type	NULL
and	NULL
truncated	NULL
CD4	NULL
mutants	NULL
were	NULL
quantified	NULL
by	NULL
phosphorimaging	NULL
,	NULL
and	NULL
ratios	NULL
were	NULL
obtained	NULL
by	NULL
normalizing	NULL
to	NULL
the	NULL
level	NULL
of	NULL
Oct-1	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Competition	NULL
experiments	NULL
to	NULL
establish	NULL
the	NULL
specificity	NULL
of	NULL
Oct-1	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
)	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
oligonucleotides	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
from	NULL
cells	NULL
expressing	NULL
CD4	NULL
wild-type	NULL
were	NULL
subjected	NULL
to	NULL
EMSA	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
positive	NULL
control	NULL
with	NULL
*°P-labelled	NULL
Oct-1	NULL
oligonucleotide	NULL
;	NULL
2	NULL
,	NULL
*°P-labelled	NULL
Oct-1	NULL
oligonucleotide	NULL
incubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
Oct-1	NULL
oligonucleotide	NULL
(	NULL
competitor	NULL
)	NULL
;	NULL
3	NULL
,	NULL
*°P-labelled	NULL
Oct-1	NULL
oligonucleotide	NULL
incubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
(	NULL
non	NULL
competitor	NULL
)	NULL
;	NULL
4	NULL
,	NULL
positive	NULL
control	NULL
with	NULL
*°P	NULL
labelled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
;	NULL
5	NULL
,	NULL
*°P-labelled	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
incubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
NF-xB	NULL
oligonucleotide	NULL
(	NULL
competitor	NULL
)	NULL
;	NULL
6	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
oligonucleotide	NULL
incubated	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
Oct-1	NULL
oligonucleotide	NULL
(	NULL
noncompetitor	NULL
)	NULL
.	NULL

8066	NULL
MOUTOUH	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
a	NULL
5	NULL
3	NULL
k	NULL
&	NULL
&	NULL
y	NULL
o	NULL
o	NULL
a	NULL
Pa	NULL
£	NULL
8	NULL
$	NULL
5	NULL
§	NULL
$	NULL
$	NULL
i	NULL
1	NULL
kpSG'Ck	NULL
45	NULL
-	NULL
i*	NULL
*	NULL
-	NULL
.	NULL

elin	NULL
-iIck	NULL
54-226	NULL
B	NULL
C	NULL
a	NULL
®	NULL
G	NULL
5	NULL
3	NULL
w	NULL
o	NULL
$	NULL
8	NULL
$	NULL
§	NULL
4	NULL
GAM	NULL
-	NULL
-	NULL
OKT-4	NULL
-	NULL
-	NULL
-	NULL
s	NULL
-_-	NULL
Amway	NULL
#	NULL
p56	NULL
’	NULL
Ck	NULL
45	NULL
GAM	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
OKT-4	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
..	NULL
_	NULL
he	NULL
aas	NULL
ume	NULL
ug	NULL
|	NULL
»	NULL
-	NULL
e	NULL
pd	NULL
=	NULL
--	NULL
trm	NULL
~	NULL
Tuk	NULL
TCI	NULL
«	NULL
-pe	NULL
!	NULL

as	NULL
--	NULL
ss	NULL
_	NULL
``	NULL
ue	NULL
-z	NULL
a-P-Tyrosine	NULL
(	NULL
4G10	NULL
)	NULL
J.	NULL
ViRoL	NULL
.	NULL

OKT-4	NULL
-	NULL
-	NULL
-	NULL
s	NULL
=	NULL
OKT-4	NULL
+	NULL
+	NULL
ﬂ	NULL
Neve	NULL
ak	NULL
-	NULL
pse	NULL
!	NULL

CK	NULL
esi	NULL
Kinase	NULL
activity	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

CD4	NULL
signaling	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
CD4	NULL
after	NULL
cross-linking	NULL
with	NULL
OKT-4	NULL
anti-CD4	NULL
MAb	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Association	NULL
of	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
with	NULL
p56	NULL
``	NULL
**	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
protein	NULL
lysate	NULL
from	NULL
CD4	NULL
wild-type	NULL
and	NULL
CD4	NULL
mutants	NULL
,	NULL
M407T	NULL
,	NULL
dileucine	NULL
(	NULL
dil	NULL
)	NULL
,	NULL
dicysteine	NULL
(	NULL
diC	NULL
)	NULL
,	NULL
and	NULL
402	NULL
truncated	NULL
were	NULL
immunopre-cipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
OKT-4	NULL
anti-CD4	NULL
MAb	NULL
.	NULL

Western	NULL
blots	NULL
of	NULL
immune	NULL
complexes	NULL
were	NULL
probed	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
p56**	NULL
.	NULL

Vector	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

Ick	NULL
of	NULL
mouse	NULL
origin	NULL
containing	NULL
the	NULL
SH3-SH2	NULL
domains	NULL
(	NULL
amino	NULL
acids	NULL
54	NULL
to	NULL
226	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Antiphosphotyrosine	NULL
(	NULL
4G10	NULL
)	NULL
immunoblots	NULL
of	NULL
wild-type	NULL
and	NULL
mutant	NULL
CD4	NULL
cellular	NULL
lysates	NULL
(	NULL
40	NULL
g	NULL
of	NULL
protein/lane	NULL
)	NULL
unstimulated	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
with	NULL
anti-CD4	NULL
MAb	NULL
(	NULL
OKT-4	NULL
)	NULL
.	NULL

Cross-linking	NULL
was	NULL
performed	NULL
as	NULL
follows	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
anti-CD4	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
with	NULL
cold	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
cross-linked	NULL
with	NULL
a	NULL
secondary	NULL
antibody	NULL
[	NULL
GAM-IgG	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
2	NULL
]	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
min	NULL
and	NULL
lysed	NULL
.	NULL

The	NULL
molecular	NULL
masses	NULL
of	NULL
the	NULL
markers	NULL
,	NULL
in	NULL
kilodaltons	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
In	NULL
vitro	NULL
kinase	NULL
activity	NULL
of	NULL
autophosphorylated	NULL
p56'**	NULL
in	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
unstimulated	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
stimulated	NULL
after	NULL
cross-linking	NULL
with	NULL
OKT-4	NULL
MAb	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

notype	NULL
is	NULL
associated	NULL
with	NULL
neither	NULL
a	NULL
particular	NULL
pattern	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
nor	NULL
p56	NULL
``	NULL
**	NULL
signaling	NULL
.	NULL

Initial	NULL
signaling	NULL
mediated	NULL
through	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
sufficient	NULL
to	NULL
predispose	NULL
HIV-infected	NULL
cells	NULL
to	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

Because	NULL
signaling	NULL
mediated	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
is	NULL
critical	NULL
to	NULL
transduce	NULL
an	NULL
apoptotic	NULL
signal	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
we	NULL
hypothesized	NULL
that	NULL
less	NULL
efficient	NULL
down-modulation	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
may	NULL
enhance	NULL
the	NULL
process	NULL
,	NULL
prolonging	NULL
the	NULL
presence	NULL
of	NULL
CD4	NULL
receptors	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
.	NULL

Nef	NULL
,	NULL
which	NULL
functions	NULL
early	NULL
in	NULL
the	NULL
viral	NULL
life	NULL
cycle	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
down-modulate	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
during	NULL
HIV	NULL
infection	NULL
.	NULL

We	NULL
analyzed	NULL
CD4	NULL
down-modulation	NULL
during	NULL
HIV	NULL
infection	NULL
of	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
or	NULL
mutated	NULL
variants	NULL
of	NULL
CD4	NULL
.	NULL

We	NULL
also	NULL
determined	NULL
whether	NULL
the	NULL
dileucine	NULL
motif	NULL
and	NULL
other	NULL
critical	NULL
hydrophobic	NULL
residues	NULL
such	NULL
as	NULL
methionine	NULL
407	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
in	NULL
Nef-induced	NULL
CD4	NULL
down-regulation	NULL
,	NULL
might	NULL
be	NULL
critical	NULL
during	NULL
an	NULL
acute	NULL
infection	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
was	NULL
evaluated	NULL
by	NULL
flow	NULL
cytometry	NULL
at	NULL
0	NULL
,	NULL
20	NULL
,	NULL
and	NULL
40	NULL
h	NULL
after	NULL
infection	NULL
with	NULL
HIV-1	NULL
;	NULL
a	NULL
,	NULL
(	NULL
MOL	NULL
,	NULL
0.1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

CD4	NULL
constructs	NULL
with	NULL
mutations	NULL
at	NULL
the	NULL
dileucine	NULL
motif	NULL
and	NULL
residue	NULL
407	NULL
were	NULL
down-regulated	NULL
as	NULL
efficiently	NULL
as	NULL
the	NULL
wild	NULL
type	NULL
.	NULL

Therefore	NULL
,	NULL
motifs	NULL
in	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
critical	NULL
for	NULL
Nef-mediated	NULL
endocytosis	NULL
did	NULL
not	NULL
affect	NULL
CD4	NULL
down-modulation	NULL
during	NULL
an	NULL
acute	NULL
HIV	NULL
infection	NULL
.	NULL

The	NULL
CD4	NULL
construct	NULL
with	NULL
the	NULL
mutation	NULL
at	NULL
the	NULL
dicysteine	NULL
motif	NULL
,	NULL
which	NULL
does	NULL
not	NULL
associate	NULL
with	NULL
p56	NULL
``	NULL
but	NULL
retains	NULL
the	NULL
full-length	NULL
cytoplasmic	NULL
tail	NULL
,	NULL
was	NULL
down-regulated	NULL
more	NULL
rapidly	NULL
than	NULL
the	NULL
wild	NULL
type	NULL
.	NULL

At	NULL
20	NULL
h	NULL
after	NULL
infection	NULL
,	NULL
more	NULL
than	NULL
50	NULL
%	NULL
of	NULL
the	NULL
surface	NULL
CD4	NULL
was	NULL
endocytosed	NULL
,	NULL
confirming	NULL
that	NULL
interaction	NULL
of	NULL
CD4	NULL
and	NULL
p56	NULL
``	NULL
**	NULL
contributes	NULL
to	NULL
maintaining	NULL
the	NULL
presence	NULL
of	NULL
CD4	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
;	NULL
however	NULL
,	NULL
the	NULL
level	NULL
of	NULL
HIV-induced	NULL
apoptosis	NULL
was	NULL
not	NULL
reduced	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
CD4	NULL
truncated	NULL
at	NULL
residue	NULL
402	NULL
was	NULL
less	NULL
down-regulated	NULL
at	NULL
20	NULL
h	NULL
,	NULL
which	NULL
may	NULL
be	NULL
a	NULL
result	NULL
of	NULL
the	NULL
resistance	NULL
of	NULL
CD4	NULL
to	NULL
[	NULL
J	NULL
20	NULL
h	NULL
after	NULL
infection	NULL
K	NULL
40	NULL
h	NULL
after	NULL
infection	NULL
402	NULL
stop	NULL
dic	NULL
dil	NULL
M4O7T	NULL
CD4	NULL
wt	NULL
1	NULL
1	NULL
1	NULL
1	NULL
I	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
100	NULL
CD4	NULL
down-modulation	NULL
(	NULL
%	NULL
)	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Down-modulation	NULL
of	NULL
CD4	NULL
in	NULL
A2.01	NULL
cells	NULL
expressing	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
CD4	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
at	NULL
0	NULL
,	NULL
20	NULL
,	NULL
and	NULL
40	NULL
h	NULL
after	NULL
infection	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
(	NULL
MOL	NULL
,	NULL
0.1	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
stained	NULL
by	NULL
direct	NULL
immunofluorescence	NULL
with	NULL
FITC-labelled	NULL
anti-CD4	NULL
MAb	NULL
OKT-4	NULL
.	NULL

For	NULL
down-regulation	NULL
of	NULL
CD4	NULL
surface	NULL
expression	NULL
at	NULL
20	NULL
and	NULL
40	NULL
h	NULL
,	NULL
a	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

dil	NULL
,	NULL
dileucine	NULL
;	NULL
diC	NULL
,	NULL
dicysteine	NULL
.	NULL

voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
10000	NULL
1000	NULL
100	NULL
10	NULL
p24	NULL
(	NULL
ng/ml	NULL
)	NULL
-	NULL
»	NULL
--	NULL
CD4	NULL
wt	NULL
-	NULL
«	NULL
-	NULL
CD4	NULL
wt	NULL
+	NULL
13B8-2	NULL
mAb	NULL
-a-	NULL
CD4	NULL
wt	NULL
+	NULL
OKT-4	NULL
mAb	NULL
0.1	NULL
1	NULL
1	NULL
1	NULL
R	NULL
_	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
Days	NULL
after	NULL
infection	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Virus	NULL
production	NULL
assessed	NULL
by	NULL
p24	NULL
antigen	NULL
level	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
CD4	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
aj	NULL
.	NULL

Cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
(	NULL
MOT	NULL
,	NULL
0.1	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
13B8-2	NULL
MAb	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
or	NULL
OKT-4	NULL
MAb	NULL
(	NULL
10	NULL
to	NULL
20	NULL
pg/ml	NULL
)	NULL
.	NULL

both	NULL
Vpu-induced	NULL
degradation	NULL
and	NULL
Nef-induced	NULL
down-regulation	NULL
when	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
deleted	NULL
(	NULL
15	NULL
,	NULL
53	NULL
)	NULL
.	NULL

By	NULL
40	NULL
h	NULL
,	NULL
wild-type	NULL
and	NULL
mutated	NULL
CD4	NULL
receptors	NULL
had	NULL
similar	NULL
levels	NULL
of	NULL
CD4	NULL
down-regulation	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
apoptosis	NULL
,	NULL
therefore	NULL
,	NULL
was	NULL
not	NULL
related	NULL
to	NULL
the	NULL
rate	NULL
of	NULL
cell	NULL
surface	NULL
CD4	NULL
down-modulation	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
initial	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
and	NULL
HIV-1	NULL
infection	NULL
are	NULL
sufficient	NULL
to	NULL
generate	NULL
the	NULL
apoptotic	NULL
potential	NULL
of	NULL
the	NULL
cell	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
modulates	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

The	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
to	NULL
find	NULL
whether	NULL
interference	NULL
with	NULL
CD4	NULL
signaling	NULL
could	NULL
modify	NULL
the	NULL
apoptotic	NULL
outcome	NULL
of	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Dimerization	NULL
is	NULL
sufficient	NULL
for	NULL
activation	NULL
of	NULL
many	NULL
receptors	NULL
.	NULL

The	NULL
CDR3-like	NULL
region	NULL
in	NULL
domain	NULL
1	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
is	NULL
critical	NULL
for	NULL
CD4	NULL
dimerization	NULL
and	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
CD4	NULL
signaling	NULL
(	NULL
11	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
anti-CD4	NULL
MAb	NULL
13B8-2	NULL
,	NULL
which	NULL
binds	NULL
the	NULL
CDR3-like	NULL
region	NULL
in	NULL
domain	NULL
1	NULL
,	NULL
might	NULL
affect	NULL
the	NULL
apoptotic	NULL
process	NULL
by	NULL
interfering	NULL
with	NULL
CD4	NULL
homodimer	NULL
formation	NULL
and	NULL
signal	NULL
transduction	NULL
.	NULL

We	NULL
also	NULL
analyzed	NULL
if	NULL
the	NULL
anti-CD4	NULL
MAb	NULL
OKT-4	NULL
,	NULL
which	NULL
binds	NULL
a	NULL
different	NULL
epitope	NULL
in	NULL
domain	NULL
4	NULL
of	NULL
the	NULL
CD4	NULL
molecule	NULL
,	NULL
interfered	NULL
with	NULL
apoptosis	NULL
.	NULL

Cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
receptors	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
(	NULL
MOI	NULL
,	NULL
0.1	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
13B8-2	NULL
MAb	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
or	NULL
OKT-4	NULL
MAb	NULL
(	NULL
10	NULL
to	NULL
20	NULL
pg/ml	NULL
)	NULL
.	NULL

Viral	NULL
production	NULL
measured	NULL
by	NULL
the	NULL
p24	NULL
antigen	NULL
ELISA	NULL
was	NULL
comparable	NULL
in	NULL
HIV-infected	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
these	NULL
MAbs	NULL
.	NULL

The	NULL
growth	NULL
rate	NULL
of	NULL
HIV	NULL
;	NULL
4	NULL
;	NULL
in	NULL
cells	NULL
Control	NULL
MOLECULAR	NULL
ANALYSIS	NULL
OF	NULL
HIV-INDUCED	NULL
APOPTOSIS	NULL
HIV	NULL
8067	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
and	NULL
in	NULL
cells	NULL
expressing	NULL
mutated	NULL
CD4	NULL
receptors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
similar	NULL
.	NULL

The	NULL
anti-CD4	NULL
MAb	NULL
13B8-2	NULL
inhibited	NULL
HIV-induced	NULL
apoptosis	NULL
without	NULL
significantly	NULL
inhibiting	NULL
viral	NULL
production	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Cells	NULL
expressing	NULL
the	NULL
CD4	NULL
mutated	NULL
at	NULL
the	NULL
dicysteine	NULL
motif	NULL
were	NULL
unstable	NULL
after	NULL
several	NULL
passages	NULL
,	NULL
and	NULL
background	NULL
levels	NULL
of	NULL
apoptosis	NULL
up	NULL
to	NULL
20	NULL
%	NULL
were	NULL
sometimes	NULL
observed	NULL
in	NULL
uninfected	NULL
cells	NULL
.	NULL

HIV-induced	NULL
apoptosis	NULL
was	NULL
efficiently	NULL
prevented	NULL
in	NULL
cells	NULL
expressing	NULL
CD4	NULL
mutations	NULL
at	NULL
residue	NULL
407	NULL
,	NULL
the	NULL
dileucine	NULL
motif	NULL
,	NULL
or	NULL
the	NULL
dicysteine	NULL
motif	NULL
or	NULL
truncated	NULL
at	NULL
residue	NULL
418	NULL
that	NULL
do	NULL
not	NULL
associate	NULL
with	NULL
p56**	NULL
.	NULL

This	NULL
effect	NULL
was	NULL
specific	NULL
to	NULL
13B8-2	NULL
MAb	NULL
,	NULL
since	NULL
apoptosis	NULL
was	NULL
not	NULL
prevented	NULL
(	NULL
wild-type	NULL
CD4	NULL
or	NULL
constructs	NULL
mutated	NULL
at	NULL
the	NULL
dileucine	NULL
motif	NULL
or	NULL
residue	NULL
407	NULL
)	NULL
or	NULL
partially	NULL
prevented	NULL
(	NULL
CD4	NULL
mutant	NULL
mutated	NULL
at	NULL
the	NULL
dicysteine	NULL
motif	NULL
or	NULL
truncated	NULL
at	NULL
residue	NULL
418	NULL
)	NULL
when	NULL
HIV-infected	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
OKT-4	NULL
MAb	NULL
.	NULL

Impor-tantly	NULL
,	NULL
13B8-2	NULL
MAb	NULL
was	NULL
able	NULL
to	NULL
prevent	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
without	NULL
inhibiting	NULL
HIV	NULL
replication	NULL
,	NULL
in	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
infected	NULL
with	NULL
HIV-1	NULL
;	NULL
a	NULL
;	NULL
(	NULL
MOI	NULL
,	NULL
0.1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
specific	NULL
signals	NULL
transduced	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
may	NULL
modify	NULL
the	NULL
apoptotic	NULL
outcome	NULL
of	NULL
HIV-infected	NULL
cells	NULL
,	NULL
substantiating	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
initial	NULL
CD4	NULL
signaling	NULL
is	NULL
determining	NULL
in	NULL
the	NULL
subsequent	NULL
propensity	NULL
of	NULL
cells	NULL
to	NULL
undergo	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

HIV-induced	NULL
apoptosis	NULL
is	NULL
not	NULL
a	NULL
consequence	NULL
of	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
but	NULL
may	NULL
be	NULL
modulated	NULL
by	NULL
Fas	NULL
signaling	NULL
.	NULL

Fas	NULL
signaling	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
during	NULL
HIV	NULL
infection	NULL
of	NULL
primary	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
speculated	NULL
that	NULL
HIV	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
may	NULL
modulate	NULL
Fas-mediated	NULL
apoptosis	NULL
by	NULL
accelerating	NULL
the	NULL
process	NULL
of	NULL
cell	NULL
death	NULL
through	NULL
up-regulation	NULL
of	NULL
Fas	NULL
ligand	NULL
expression	NULL
(	NULL
57	NULL
)	NULL
.	NULL

Cells	NULL
expressing	NULL
either	NULL
wild-type	NULL
CD4	NULL
or	NULL
mutants	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
constitutively	NULL
expressed	NULL
Fas	NULL
(	NULL
97	NULL
%	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
role	NULL
of	NULL
Fas	NULL
signaling	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
three	NULL
different	NULL
anti-Fas	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
(	NULL
i	NULL
)	NULL
clone	NULL
CH-11	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
soluble	NULL
Fas-Fc	NULL
,	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
clone	NULL
ZB4	NULL
.	NULL

The	NULL
prototypic	NULL
MAb	NULL
CH-11	NULL
(	NULL
IgM	NULL
)	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
agonistic	NULL
anti-Fas	NULL
antibody	NULL
since	NULL
it	NULL
induces	NULL
Fas	NULL
signaling	NULL
and	NULL
apoptosis	NULL
.	NULL

The	NULL
antagonistic	NULL
anti-Fas	NULL
chimeric	NULL
antibody	NULL
Fas-Fc	NULL
prevents	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
acting	NULL
as	NULL
a	NULL
competitive	NULL
inhibitor	NULL
.	NULL

MAb	NULL
ZB4	NULL
(	NULL
IgG1	NULL
)	NULL
is	NULL
referred	NULL
to	NULL
as	NULL
antagonistic	NULL
anti-Fas	NULL
antibody	NULL
since	NULL
it	NULL
prevents	NULL
signaling	NULL
mediated	NULL
by	NULL
CH-11	NULL
MAb	NULL
and	NULL
consequently	NULL
prevents	NULL
apoptosis	NULL
(	NULL
26	NULL
)	NULL
.	NULL

We	NULL
verified	NULL
first	NULL
that	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
A2.01	NULL
cell	NULL
lines	NULL
(	NULL
wild-type	NULL
and	NULL
mutant	NULL
CD4	NULL
)	NULL
were	NULL
sensitive	NULL
to	NULL
Fas-mediated	NULL
apoptosis	NULL
by	NULL
using	NULL
the	NULL
prototypic	NULL
CH-11	NULL
MAb	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

Then	NULL
,	NULL
to	NULL
study	NULL
the	NULL
role	NULL
of	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
in	NULL
the	NULL
apoptotic	NULL
process	NULL
,	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
were	NULL
infected	NULL
with	NULL
HIV	NULL
while	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
was	NULL
blocked	NULL
HIV	NULL
+	NULL
13B8.2	NULL
_	NULL
10	NULL
%	NULL
Cell	NULL
number	NULL
17	NULL
%	NULL
Intensity	NULL
of	NULL
fluorescence	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

The	NULL
anti-CD4	NULL
MAb	NULL
13B8-2	NULL
inhibits	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
in	NULL
primary	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Purified	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
fresh	NULL
medium	NULL
containing	NULL
rIL-2	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
40	NULL
U/ml	NULL
!	NULL
)	NULL

and	NULL
stimulated	NULL
with	NULL
phytohemagglutinin	NULL
(	NULL
3	NULL
ug/ml	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

After	NULL
72	NULL
h	NULL
of	NULL
stimulation	NULL
,	NULL
CD4*	NULL
T	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
HIV-1	NULL
;	NULL
a	NULL
,	NULL
(	NULL
MOL	NULL
,	NULL
0.1	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
fresh	NULL
medium	NULL
containing	NULL
rIL-2	NULL
(	NULL
final	NULL
concentration	NULL
,	NULL
40	NULL
U/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
13B8-2	NULL
MAb	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
.	NULL

Apoptosis	NULL
assessed	NULL
by	NULL
fluorochrome-labelled	NULL
annexin-V	NULL
binding	NULL
on	NULL
day	NULL
4	NULL
after	NULL
infection	NULL
is	NULL
represented	NULL
.	NULL

8068	NULL
MOUTOUH	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

The	NULL
anti-CD4	NULL
MAb	NULL
13B8-2	NULL
inhibits	NULL
HIV-mediated	NULL
apoptosis	NULL
in	NULL
A2.01	NULL
cells	NULL
expressing	NULL
the	NULL
CD4	NULL
receptor	NULL
%	NULL
of	NULL
apoptotic	NULL
cells	NULL
at	NULL
day	NULL
4	NULL
after	NULL
infection	NULL
``	NULL
p24	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

at	NULL
day	NULL
4	NULL
after	NULL
infection	NULL
CD4	NULL
HIV	NULL
+	NULL
HIV	NULL
+	NULL
HIV	NULL
+	NULL
HIV	NULL
+	NULL
HIV	NULL
13B8-2	NULL
OKT-4	NULL
HIV	NULL
13B8-2	NULL
OKT-4	NULL
Wild	NULL
type	NULL
21.8	NULL
11.8	NULL
20.9	NULL
1,180	NULL
1,380	NULL
2,890	NULL
M407T	NULL
22.4	NULL
9.7	NULL
24.7	NULL
1,170	NULL
3,080	NULL
2,410	NULL
dileucine	NULL
19	NULL
74	NULL
21.9	NULL
2,100	NULL
2,610	NULL
1,590	NULL
dicysteine	NULL
11	NULL
0.5	NULL
8	NULL
2,750	NULL
1,060	NULL
790	NULL
402	NULL
truncated	NULL
4.4	NULL
2.5	NULL
5.6	NULL
1,140	NULL
2,560	NULL
1,060	NULL
418	NULL
truncated	NULL
_	NULL
11.8	NULL
2.8	NULL
6.2	NULL
2,400	NULL
1,270	NULL
1,780	NULL
``	NULL
Apoptosis	NULL
was	NULL
assessed	NULL
by	NULL
cell	NULL
cycle	NULL
analysis	NULL
by	NULL
flow	NULL
cytometry	NULL
with	NULL
propidium	NULL
iodide	NULL
.	NULL

Percentages	NULL
of	NULL
apoptotic	NULL
cells	NULL
were	NULL
obtained	NULL
by	NULL
subtracting	NULL
background	NULL
apoptosis	NULL
for	NULL
uninfected	NULL
cell	NULL
lines	NULL
.	NULL

Levels	NULL
of	NULL
apoptosis	NULL
in	NULL
uninfected	NULL
cells	NULL
ranged	NULL
between	NULL
4	NULL
to	NULL
8	NULL
%	NULL
(	NULL
except	NULL
for	NULL
cells	NULL
expressing	NULL
the	NULL
dicysteine	NULL
,	NULL
mutant	NULL
where	NULL
background	NULL
was	NULL
up	NULL
to	NULL
20	NULL
%	NULL
)	NULL
.	NULL

with	NULL
the	NULL
antagonistic	NULL
decoy	NULL
Fas	NULL
chimeric	NULL
antibody	NULL
(	NULL
Fas-Fc	NULL
,	NULL
10	NULL
g/ml	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
apoptosis	NULL
was	NULL
monitored	NULL
by	NULL
light	NULL
microscopy	NULL
and	NULL
flow	NULL
cytometry	NULL
(	NULL
fluorochrome-labeled	NULL
annexin-V	NULL
binding	NULL
)	NULL
.	NULL

Soluble	NULL
Fas-Fc	NULL
,	NULL
which	NULL
efficiently	NULL
abrogated	NULL
apoptosis	NULL
mediated	NULL
by	NULL
agonistic	NULL
Fas	NULL
IgM	NULL
antibody	NULL
clone	NULL
CH-11	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
,	NULL
did	NULL
not	NULL
prevent	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
.	NULL

To	NULL
further	NULL
confirm	NULL
that	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
was	NULL
not	NULL
the	NULL
mechanism	NULL
involved	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
Fas	NULL
ligand	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
and	NULL
Fas	NULL
ligand	NULL
mRNA	NULL
upon	NULL
HIV-1	NULL
;	NULL
a	NULL
,	NULL
infection	NULL
.	NULL

Cell	NULL
surface	NULL
expression	NULL
of	NULL
Fas	NULL
ligand	NULL
,	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
biotin-conjugated	NULL
anti-FasL	NULL
MAb	NULL
clone	NULL
NOK-1	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
metallopro-	NULL
A	NULL
B	NULL
{	NULL
-	NULL
control	NULL
H	NULL
-	NULL
CH-11	NULL
mAb	NULL
(	NULL
J	NULL
_	NULL
CH-11	NULL
mAb	NULL
+	NULL
soluble	NULL
Fas-Fc	NULL
40	NULL
-	NULL
EH	NULL
-	NULL
soluble	NULL
Fas-Fc	NULL
£	NULL
-	NULL
so	NULL
2	NULL
©	NULL
0	NULL
0	NULL
20	NULL
~I	NULL
a	NULL
0	NULL
«	NULL
a	NULL
.	NULL

3	NULL
<	NULL
10	NULL
0	NULL
_	NULL
]	NULL
CD4	NULL
wt	NULL
FasL	NULL
B-actin	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
J.	NULL
ViRoL	NULL
.	NULL

teinase	NULL
inhibitor	NULL
)	NULL
0	NULL
and	NULL
48	NULL
h	NULL
after	NULL
infection	NULL
,	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
receptors	NULL
and	NULL
was	NULL
not	NULL
up-regulated	NULL
upon	NULL
HIV-1	NULL
;	NULL
a	NULL
;	NULL
infection	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Fas	NULL
ligand	NULL
mRNA	NULL
expression	NULL
,	NULL
analyzed	NULL
by	NULL
RT-PCR	NULL
at	NULL
0	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
after	NULL
infection	NULL
,	NULL
was	NULL
detected	NULL
only	NULL
in	NULL
A2.01	NULL
cells	NULL
expressing	NULL
the	NULL
dicysteine	NULL
and	NULL
the	NULL
418	NULL
truncated	NULL
mutant	NULL
and	NULL
was	NULL
not	NULL
upregulated	NULL
upon	NULL
HIV	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

9C	NULL
)	NULL
.	NULL

This	NULL
low	NULL
level	NULL
of	NULL
basal	NULL
Fas	NULL
ligand	NULL
mRNA	NULL
expression	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
dicysteine	NULL
and	NULL
truncated	NULL
418	NULL
mutants	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
lower	NULL
stability	NULL
of	NULL
CD4	NULL
on	NULL
these	NULL
cells	NULL
after	NULL
several	NULL
passages	NULL
in	NULL
comparison	NULL
to	NULL
that	NULL
of	NULL
cells	NULL
expressing	NULL
CD4	NULL
wild-type	NULL
or	NULL
mutant	NULL
M407T	NULL
,	NULL
dileucine	NULL
,	NULL
or	NULL
402	NULL
stop	NULL
.	NULL

Lastly	NULL
,	NULL
to	NULL
study	NULL
if	NULL
Fas	NULL
signaling	NULL
may	NULL
be	NULL
modulated	NULL
in	NULL
HIV-infected	NULL
cells	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
extent	NULL
of	NULL
apoptosis	NULL
in	NULL
the	NULL
different	NULL
cell	NULL
lines	NULL
infected	NULL
with	NULL
HIV-1	NULL
;	NULL
4	NULL
;	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
antagonistic	NULL
anti-Fas	NULL
antibody	NULL
clone	NULL
ZB4	NULL
.	NULL

ZB4	NULL
antibody	NULL
inhibited	NULL
cell	NULL
death	NULL
in	NULL
either	NULL
HIV-infected	NULL
cells	NULL
or	NULL
uninfected	NULL
cells	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CH-11	NULL
antibody	NULL
(	NULL
0.2	NULL
pg/ml	NULL
)	NULL
;	NULL
the	NULL
level	NULL
of	NULL
inhibition	NULL
of	NULL
Fas-mediated	NULL
apoptosis	NULL
was	NULL
modulated	NULL
over	NULL
time	NULL
,	NULL
with	NULL
complete	NULL
inhibition	NULL
at	NULL
4	NULL
h	NULL
but	NULL
partial	NULL
inhibition	NULL
at	NULL
24	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
increased	NULL
considerably	NULL
when	NULL
HIV-infected	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ZB4	NULL
antibody	NULL
(	NULL
0.2	NULL
pg/ml	NULL
)	NULL
compared	NULL
to	NULL
cells	NULL
cultured	NULL
without	NULL
ZB4	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

10	NULL
)	NULL
.	NULL

As	NULL
reported	NULL
by	NULL
others	NULL
,	NULL
in	NULL
uninfected	NULL
cells	NULL
this	NULL
antibody	NULL
did	NULL
not	NULL
induce	NULL
apoptotic	NULL
cell	NULL
death	NULL
;	NULL
however	NULL
,	NULL
in	NULL
HIV-infected	NULL
cells	NULL
this	NULL
anti-Fas	NULL
antibody	NULL
considerably	NULL
potentiated	NULL
apoptosis	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
outcome	NULL
of	NULL
Fas	NULL
signaling	NULL
with	NULL
ZB4	NULL
MAb	NULL
was	NULL
different	NULL
in	NULL
noninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
A2.01	NULL
does	NULL
not	NULL
involve	NULL
Fas	NULL
Q	NULL
-	NULL
HIV	NULL
B	NULL
-	NULL
HIV	NULL
+	NULL
soluble	NULL
Fas-Fc	NULL
B	NULL
)	NULL
-	NULL
uninfected	NULL
control	NULL
30	NULL
€	NULL
a	NULL
o	NULL
207	NULL
p	NULL
0	NULL
C	NULL
9	NULL
G	NULL
§	NULL
10	NULL
<	NULL
o	NULL
CD4	NULL
wt	NULL
402	NULL
stop	NULL
dic	NULL
418	NULL
stop	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Cell	NULL
death	NULL
in	NULL
A2.01	NULL
cells	NULL
expressing	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
CD4	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Susceptibility	NULL
of	NULL
A2.01	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
to	NULL
the	NULL
agonistic	NULL
anti-Fas	NULL
antibody	NULL
(	NULL
clone	NULL
CH-11	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
in	NULL
cells	NULL
cultured	NULL
for	NULL
4	NULL
h	NULL
with	NULL
CH-11	NULL
MAb	NULL
(	NULL
0.2	NULL
pg/ml	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
the	NULL
antagonistic	NULL
decoy	NULL
Fas	NULL
antibody	NULL
(	NULL
Fas-Fc	NULL
,	NULL
10	NULL
ug/	NULL
ml	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Apoptosis	NULL
upon	NULL
HIV-1	NULL
infection	NULL
in	NULL
wild-type	NULL
and	NULL
mutant	NULL
CD4	NULL
while	NULL
preventing	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
with	NULL
the	NULL
antagonistic	NULL
decoy	NULL
Fas	NULL
antibody	NULL
(	NULL
Fas-Fc	NULL
10	NULL
pg/ml	NULL
)	NULL
.	NULL

Infected	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
soluble	NULL
Fas-Fc	NULL
for	NULL
3	NULL
days	NULL
,	NULL
and	NULL
apoptosis	NULL
was	NULL
assessed	NULL
by	NULL
fluorochrome-labelled	NULL
annexin-V	NULL
binding	NULL
on	NULL
day	NULL
3	NULL
after	NULL
infection	NULL
.	NULL

HIV-infected	NULL
cells	NULL
cultured	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
soluble	NULL
Fas-Fc	NULL
and	NULL
uninfected	NULL
cells	NULL
are	NULL
represented	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
individual	NULL
experiments	NULL
.	NULL

diC	NULL
,	NULL
dicysteine	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Fas	NULL
ligand	NULL
mRNA	NULL
expression	NULL
in	NULL
wild-type	NULL
CD4	NULL
and	NULL
CD4	NULL
mutants	NULL
infected	NULL
with	NULL
HIV	NULL
;	NULL
a	NULL
;	NULL
.	NULL

RNAs	NULL
prepared	NULL
from	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
at	NULL
0	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
after	NULL
infection	NULL
were	NULL
reverse	NULL
transcribed	NULL
into	NULL
cDNAs	NULL
,	NULL
and	NULL
the	NULL
products	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
FasL	NULL
and	NULL
B-actin	NULL
primers	NULL
.	NULL

Results	NULL
for	NULL
wild-type	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
)	NULL
,	NULL
402	NULL
truncated	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
and	NULL
10	NULL
)	NULL
,	NULL
diC	NULL
(	NULL
lane	NULL
3	NULL
,	NULL
7	NULL
and	NULL
11	NULL
)	NULL
and	NULL
418	NULL
truncated	NULL
(	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
and	NULL
12	NULL
)	NULL
CD4	NULL
are	NULL
shown	NULL
.	NULL

voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
120	NULL
7	NULL
100	NULL
To	NULL
E	NULL
-	NULL
so-2	NULL
cd	NULL
o	NULL
0	NULL
60	NULL
7	NULL
p=l	NULL
2	NULL
5	NULL
a	NULL
.	NULL

40	NULL
7	NULL
<	NULL
4	NULL
207	NULL
o	NULL
B=	NULL
G	NULL
~	NULL
2	NULL
~R	NULL
goon	NULL
bos	NULL
4	NULL
os	NULL
4+	NULL
$	NULL
&	NULL
-	NULL
$	NULL
-p	NULL
o-	NULL
+	NULL
>	NULL
np	NULL
2B4	NULL
tok	NULL
n	NULL
9	NULL
oto	NULL
e	NULL
~	NULL
od	NULL
4	NULL
s	NULL
~	NULL
opp	NULL
n	NULL
>	NULL
4	NULL
go	NULL
>	NULL
NC	NULL
HIV	NULL
|	NULL
,	NULL
CD4	NULL
wt	NULL
402	NULL
stop	NULL
diC	NULL
418	NULL
stop	NULL
Vector	NULL
FIG	NULL
.	NULL

10	NULL
.	NULL

Apoptosis	NULL
upon	NULL
HIV-1	NULL
infection	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
(	NULL
wt	NULL
)	NULL
or	NULL
mutant	NULL
CD4	NULL
while	NULL
preventing	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
with	NULL
the	NULL
IgG1	NULL
anti-Fas	NULL
antibody	NULL
ZB4	NULL
(	NULL
0.2	NULL
ug/ml	NULL
)	NULL
.	NULL

Apoptosis	NULL
in	NULL
HIV-infected	NULL
and	NULL
uninfected	NULL
cells	NULL
was	NULL
measured	NULL
each	NULL
day	NULL
under	NULL
light	NULL
microscopy	NULL
.	NULL

Apoptosis	NULL
on	NULL
day	NULL
4	NULL
after	NULL
infection	NULL
,	NULL
after	NULL
72	NULL
h	NULL
of	NULL
treatment	NULL
with	NULL
ZB4	NULL
MAb	NULL
,	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
results	NULL
presented	NULL
are	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

diC	NULL
,	NULL
dicysteine	NULL
.	NULL

Fas	NULL
ligand	NULL
interaction	NULL
,	NULL
despite	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
functional	NULL
Fas	NULL
pathway	NULL
,	NULL
but	NULL
remains	NULL
sensitive	NULL
to	NULL
Fas	NULL
modulation	NULL
as	NULL
exemplified	NULL
by	NULL
potentiation	NULL
of	NULL
cell	NULL
death	NULL
by	NULL
ZB4	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Our	NULL
group	NULL
previously	NULL
demonstrated	NULL
that	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
required	NULL
for	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
role	NULL
played	NULL
by	NULL
CD4	NULL
signaling	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
and	NULL
determinated	NULL
whether	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
and	NULL
Fas	NULL
pathway	NULL
were	NULL
involved	NULL
in	NULL
this	NULL
process	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
role	NULL
played	NULL
by	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
in	NULL
the	NULL
process	NULL
of	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
wild-type	NULL
and	NULL
mutated	NULL
CD4	NULL
receptors	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
A2.01	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
,	NULL
a	NULL
variant	NULL
of	NULL
the	NULL
A3.01	NULL
T-cell	NULL
line	NULL
that	NULL
lacks	NULL
CD4	NULL
expression	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
tail	NULL
was	NULL
essential	NULL
in	NULL
delivering	NULL
a	NULL
signal	NULL
for	NULL
apoptosis	NULL
during	NULL
HIV-1	NULL
infection	NULL
,	NULL
independent	NULL
of	NULL
the	NULL
CD4-p56	NULL
``	NULL
*	NULL
association	NULL
.	NULL

More	NULL
specifically	NULL
,	NULL
the	NULL
sequence	NULL
located	NULL
between	NULL
amino	NULL
acid	NULL
residues	NULL
402	NULL
and	NULL
418	NULL
of	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
acutely	NULL
infected	NULL
cells	NULL
.	NULL

The	NULL
growth	NULL
rates	NULL
of	NULL
HIV	NULL
were	NULL
comparable	NULL
in	NULL
an	NULL
acute	NULL
infection	NULL
of	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutated	NULL
CD4	NULL
receptors	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
potential	NULL
for	NULL
transducing	NULL
an	NULL
apoptotic	NULL
signal	NULL
was	NULL
not	NULL
related	NULL
to	NULL
differences	NULL
in	NULL
viral	NULL
production	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
mediating	NULL
apoptosis	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
or	NULL
mutant	NULL
CD4	NULL
receptor	NULL
was	NULL
addressed	NULL
,	NULL
since	NULL
NF-kB	NULL
activation	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
either	NULL
protect	NULL
or	NULL
induce	NULL
apoptotic	NULL
cell	NULL
death	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
34	NULL
,	NULL
52	NULL
)	NULL
.	NULL

In	NULL
our	NULL
acute-infection	NULL
model	NULL
,	NULL
the	NULL
propensity	NULL
of	NULL
cells	NULL
expressing	NULL
different	NULL
CD4	NULL
molecules	NULL
to	NULL
undergo	NULL
apoptosis	NULL
was	NULL
not	NULL
related	NULL
to	NULL
differences	NULL
in	NULL
basal	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
and	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
.	NULL

Cell	NULL
death	NULL
was	NULL
also	NULL
unrelated	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
gene	NULL
products	NULL
from	NULL
the	NULL
Bel-2	NULL
family	NULL
(	NULL
Bel-2	NULL
,	NULL
Bel-XL	NULL
,	NULL
and	NULL
Bax	NULL
)	NULL
that	NULL
modulate	NULL
apoptosis	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Cross-linking	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
by	NULL
anti-CD4	NULL
MAb	NULL
or	NULL
HIV	NULL
envelope	NULL
protein	NULL
gp120	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
reduce	NULL
the	NULL
expression	NULL
of	NULL
Bel-2	NULL
in	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
A2.01	NULL
lymphoblastoid	NULL
T	NULL
cells	NULL
expressing	NULL
wild-type	NULL
MOLECULAR	NULL
ANALYSIS	NULL
OF	NULL
HIV-INDUCED	NULL
APOPTOSIS	NULL
-	NULL
8069	NULL
and	NULL
mutated	NULL
CD4	NULL
receptors	NULL
lacked	NULL
endogenous	NULL
Bax	NULL
(	NULL
death	NULL
promoting	NULL
)	NULL
and	NULL
presented	NULL
no	NULL
striking	NULL
difference	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
Bel-2	NULL
or	NULL
Bel-XL	NULL
(	NULL
survival	NULL
factor	NULL
)	NULL
durin	NULL
%	NULL
HIV	NULL
infection	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
association	NULL
of	NULL
p56**	NULL
with	NULL
CD4	NULL
,	NULL
mediated	NULL
through	NULL
cysteine	NULL
motifs	NULL
in	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
CD4	NULL
and	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
p56**	NULL
(	NULL
69	NULL
)	NULL
,	NULL
is	NULL
critical	NULL
for	NULL
CD4-mediated	NULL
signaling	NULL
in	NULL
T-cell	NULL
activation	NULL
(	NULL
31	NULL
,	NULL
63	NULL
,	NULL
73	NULL
)	NULL
.	NULL

However	NULL
,	NULL
some	NULL
reports	NULL
support	NULL
a	NULL
signaling	NULL
role	NULL
for	NULL
the	NULL
CD4	NULL
receptor	NULL
without	NULL
involving	NULL
the	NULL
p56	NULL
``	NULL
**	NULL
protein	NULL
(	NULL
46	NULL
,	NULL
51	NULL
)	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
required	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
;	NULL
however	NULL
,	NULL
the	NULL
apoptotic	NULL
process	NULL
was	NULL
indegendcnt	NULL
of	NULL
the	NULL
association	NULL
of	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p56	NULL
``	NULL
**	NULL
with	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
CD4	NULL
and	NULL
did	NULL
not	NULL
require	NULL
activation	NULL
of	NULL
p56**	NULL
signaling	NULL
.	NULL

The	NULL
stability	NULL
of	NULL
CD4	NULL
expression	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
was	NULL
lower	NULL
for	NULL
the	NULL
dicysteine	NULL
and	NULL
the	NULL
418	NULL
truncated	NULL
mutants	NULL
,	NULL
and	NULL
this	NULL
instability	NULL
increased	NULL
with	NULL
passaging	NULL
.	NULL

This	NULL
lower	NULL
stability	NULL
was	NULL
reflected	NULL
by	NULL
the	NULL
variability	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
apoptosis	NULL
observed	NULL
for	NULL
these	NULL
mutants	NULL
in	NULL
the	NULL
data	NULL
presented	NULL
in	NULL
Table	NULL
1	NULL
in	NULL
comparison	NULL
to	NULL
Fig	NULL
.	NULL

3	NULL
and	NULL
10	NULL
,	NULL
with	NULL
lower	NULL
and	NULL
comparable	NULL
levels	NULL
of	NULL
apoptosis	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
CD4	NULL
respectively	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
CD4-p56	NULL
``	NULL
**	NULL
association	NULL
,	NULL
these	NULL
cells	NULL
underwent	NULL
apoptosis	NULL
,	NULL
demonstrating	NULL
that	NULL
p56	NULL
``	NULL
**	NULL
was	NULL
not	NULL
critical	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

CD4	NULL
expression	NULL
was	NULL
stable	NULL
for	NULL
wild-type	NULL
CD4	NULL
and	NULL
the	NULL
other	NULL
mutants	NULL
(	NULL
M407T	NULL
,	NULL
dileucine	NULL
,	NULL
and	NULL
402	NULL
truncated	NULL
)	NULL
that	NULL
could	NULL
associate	NULL
with	NULL
p56**	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
expression	NULL
of	NULL
p56	NULL
``	NULL
**	NULL
in	NULL
C8166-45	NULL
or	NULL
MT-2	NULL
cells	NULL
,	NULL
both	NULL
deficient	NULL
in	NULL
p56	NULL
“	NULL
,	NULL
increased	NULL
HIV-induced	NULL
apoptosis	NULL
and	NULL
syncytium	NULL
formation	NULL
(	NULL
21	NULL
)	NULL
;	NULL
the	NULL
role	NULL
of	NULL
p56**	NULL
in	NULL
these	NULL
studies	NULL
may	NULL
have	NULL
been	NULL
to	NULL
maintain	NULL
CD4	NULL
to	NULL
the	NULL
cell	NULL
surface	NULL
for	NULL
a	NULL
longer	NULL
period	NULL
(	NULL
58	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
another	NULL
signaling	NULL
pathway	NULL
,	NULL
independent	NULL
of	NULL
Ick	NULL
,	NULL
is	NULL
participating	NULL
in	NULL
HIV-induced	NULL
apoptosis	NULL
and	NULL
that	NULL
residues	NULL
in	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
proximal	NULL
to	NULL
the	NULL
p56	NULL
``	NULL
**	NULL
binding	NULL
domain	NULL
are	NULL
critical	NULL
to	NULL
transduce	NULL
the	NULL
apoptotic	NULL
signal	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
prolonging	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
would	NULL
increase	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
we	NULL
examined	NULL
CD4	NULL
down-regulation	NULL
during	NULL
HIV	NULL
infection	NULL
in	NULL
cells	NULL
expressing	NULL
wild-type	NULL
and	NULL
mutant	NULL
CD4	NULL
receptors	NULL
.	NULL

Constructs	NULL
with	NULL
mutations	NULL
at	NULL
the	NULL
dileucine	NULL
motif	NULL
and	NULL
residue	NULL
407	NULL
were	NULL
of	NULL
particular	NULL
interest	NULL
since	NULL
expression	NULL
of	NULL
Nef	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
mediate	NULL
endocytosis	NULL
of	NULL
CD4	NULL
from	NULL
the	NULL
cell	NULL
surface	NULL
through	NULL
a	NULL
dileucine	NULL
motif	NULL
in	NULL
the	NULL
cytoplasmic	NULL
tail	NULL
(	NULL
1	NULL
,	NULL
33	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
hydrophobic	NULL
residue	NULL
407	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
contribute	NULL
to	NULL
CD4	NULL
down-modulation	NULL
by	NULL
Nef	NULL
(	NULL
41	NULL
,	NULL
60	NULL
)	NULL
.	NULL

However	NULL
,	NULL
under	NULL
our	NULL
conditions	NULL
of	NULL
acute	NULL
HIV-1	NULL
infection	NULL
and	NULL
in	NULL
contrast	NULL
to	NULL
studies	NULL
of	NULL
transiently	NULL
coexpressed	NULL
Nef	NULL
and	NULL
CD4	NULL
,	NULL
CD4	NULL
down-modulation	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
mutant	NULL
receptors	NULL
compared	NULL
with	NULL
wild-type	NULL
CD4	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
cooperative	NULL
effects	NULL
of	NULL
Vpu	NULL
and	NULL
Env	NULL
may	NULL
be	NULL
sufficient	NULL
to	NULL
compensate	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
Nef	NULL
in	NULL
effecting	NULL
CD4	NULL
down-modulation	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
dileucine	NULL
motif	NULL
and	NULL
residue	NULL
407	NULL
are	NULL
not	NULL
critical	NULL
for	NULL
CD4	NULL
down-regulation	NULL
during	NULL
an	NULL
acute	NULL
HIV-1	NULL
infection	NULL
of	NULL
lymphoblastoid	NULL
T	NULL
cells	NULL
,	NULL
despite	NULL
the	NULL
apparent	NULL
function	NULL
of	NULL
Nef	NULL
in	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
virus	NULL
infection	NULL
(	NULL
14	NULL
,	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

The	NULL
CD4	NULL
receptor	NULL
mutated	NULL
at	NULL
the	NULL
dicysteine	NULL
motif	NULL
was	NULL
down-regulated	NULL
more	NULL
rapidly	NULL
than	NULL
was	NULL
wild-type	NULL
CD4	NULL
after	NULL
HIV-1	NULL
infection	NULL
;	NULL
however	NULL
,	NULL
this	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
,	NULL
suggesting	NULL
that	NULL
initial	NULL
signaling	NULL
through	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
a	NULL
primary	NULL
determinant	NULL
for	NULL
the	NULL
subsequent	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Jacotot	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
dispensable	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
;	NULL
however	NULL
,	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
CD4	NULL
expression	NULL
was	NULL
not	NULL
comparable	NULL
to	NULL
wild-type	NULL
CD4	NULL
and	NULL
was	NULL
heterogeneous	NULL
in	NULL
cells	NULL
expressing	NULL
the	NULL
truncated	NULL
CD4	NULL
receptor	NULL
.	NULL

The	NULL
conditions	NULL
of	NULL
infection	NULL
were	NULL
different	NULL
since	NULL
these	NULL
authors	NULL
used	NULL
a	NULL
lower	NULL
MOI	NULL
.	NULL

Nevertheless	NULL
,	NULL
8070	NULL
MOUTOUH	NULL
ET	NULL
AL	NULL
.	NULL

apoptosis	NULL
was	NULL
still	NULL
delayed	NULL
in	NULL
HIV-infected	NULL
cells	NULL
expressing	NULL
the	NULL
truncated	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

Lastly	NULL
,	NULL
apoptosis	NULL
was	NULL
monitored	NULL
by	NULL
analyzing	NULL
DNA	NULL
fragmentation	NULL
and	NULL
the	NULL
presence	NULL
of	NULL
nucleosomal	NULL
histone	NULL
which	NULL
detect	NULL
cells	NULL
in	NULL
the	NULL
late	NULL
phases	NULL
of	NULL
apoptosis	NULL
.	NULL

Here	NULL
,	NULL
apoptosis	NULL
was	NULL
assessed	NULL
by	NULL
three	NULL
different	NULL
methods	NULL
:	NULL
fluorochrome	NULL
labeled	NULL
annexin-V	NULL
binding	NULL
(	NULL
an	NULL
early	NULL
step	NULL
)	NULL
,	NULL
cell	NULL
cycle	NULL
analysis	NULL
and	NULL
light	NULL
microscopy	NULL
,	NULL
all	NULL
of	NULL
which	NULL
gave	NULL
concordant	NULL
results	NULL
which	NULL
confirmed	NULL
that	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
is	NULL
critical	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
an	NULL
acute	NULL
infection	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
HIV	NULL
infection	NULL
could	NULL
generate	NULL
a	NULL
pre-apoptotic	NULL
state	NULL
in	NULL
HIV-infected	NULL
cells	NULL
by	NULL
lowering	NULL
the	NULL
signal	NULL
threshold	NULL
that	NULL
primes	NULL
for	NULL
apoptosis	NULL
.	NULL

Additional	NULL
signals	NULL
mediated	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
and	NULL
the	NULL
Fas/CD95	NULL
molecule	NULL
were	NULL
able	NULL
to	NULL
modulate	NULL
the	NULL
apoptotic	NULL
outcome	NULL
of	NULL
HIV	NULL
infection	NULL
.	NULL

Anti-CD4	NULL
antibody	NULL
13B8-2	NULL
inhibited	NULL
HIV-induced	NULL
apoptosis	NULL
in	NULL
productively	NULL
infected	NULL
A2.01	NULL
lymphoblastoid	NULL
T-cell	NULL
line	NULL
,	NULL
independently	NULL
of	NULL
its	NULL
antiviral	NULL
effect	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
phenotype	NULL
was	NULL
confirmed	NULL
in	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
results	NULL
of	NULL
Benkirane	NULL
et	NULL
al	NULL
.	NULL

(	NULL
8	NULL
)	NULL
,	NULL
HIV	NULL
production	NULL
was	NULL
unaffected	NULL
by	NULL
13B8-2	NULL
MAb	NULL
treatment	NULL
.	NULL

The	NULL
reason	NULL
for	NULL
this	NULL
discrepancy	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
13B8-2	NULL
MAb	NULL
to	NULL
inhibit	NULL
HIV-1	NULL
replication	NULL
may	NULL
be	NULL
the	NULL
conditions	NULL
of	NULL
infection	NULL
used	NULL
.	NULL

We	NULL
used	NULL
a	NULL
200-	NULL
to	NULL
1,000-fold	NULL
higher	NULL
multiplicity	NULL
of	NULL
infection	NULL
(	NULL
MOI	NULL
of	NULL
0.1	NULL
to	NULL
0.5	NULL
)	NULL
and	NULL
allowed	NULL
fusion	NULL
of	NULL
virions	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
to	NULL
proceed	NULL
at	NULL
37°C	NULL
.	NULL

Under	NULL
such	NULL
conditions	NULL
,	NULL
the	NULL
effect	NULL
of	NULL
13B8-2	NULL
MAb	NULL
treatment	NULL
on	NULL
HIV	NULL
production	NULL
was	NULL
not	NULL
apparent	NULL
,	NULL
despite	NULL
preventing	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
13B8-2	NULL
interferes	NULL
with	NULL
the	NULL
transduction	NULL
of	NULL
an	NULL
apoptotic	NULL
signal	NULL
during	NULL
acute	NULL
HIV	NULL
infection	NULL
.	NULL

Moreover	NULL
,	NULL
this	NULL
effect	NULL
was	NULL
specific	NULL
to	NULL
MAb	NULL
13B8-2	NULL
,	NULL
since	NULL
OKT	NULL
which	NULL
also	NULL
binds	NULL
CD4	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
HIV-induced	NULL
apoptosis	NULL
.	NULL

Hypothetically	NULL
,	NULL
13B8-2	NULL
might	NULL
rescue	NULL
infected	NULL
cells	NULL
from	NULL
apoptosis	NULL
by	NULL
interfering	NULL
with	NULL
the	NULL
dimerization	NULL
process	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
and	NULL
CD4	NULL
signaling	NULL
that	NULL
triggers	NULL
apoptosis	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
negative	NULL
charges	NULL
on	NULL
the	NULL
CDR3-like	NULL
region	NULL
of	NULL
CD4	NULL
domain	NULL
1	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
CD4-mediated	NULL
signal	NULL
transduction	NULL
and	NULL
may	NULL
represent	NULL
a	NULL
major	NULL
site	NULL
for	NULL
CD4	NULL
dimerization	NULL
(	NULL
9-11	NULL
,	NULL
30	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
dimerization	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
may	NULL
be	NULL
a	NULL
general	NULL
mechanism	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
signal	NULL
transduction	NULL
(	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
13B8-2	NULL
partially	NULL
affects	NULL
gp120-CD4	NULL
association	NULL
and	NULL
interferes	NULL
with	NULL
membrane	NULL
fusion	NULL
;	NULL
conflicting	NULL
data	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
the	NULL
CDR3	NULL
region	NULL
,	NULL
either	NULL
confirming	NULL
(	NULL
13	NULL
)	NULL
or	NULL
refuting	NULL
(	NULL
12	NULL
)	NULL
a	NULL
role	NULL
for	NULL
the	NULL
CDR3	NULL
region	NULL
in	NULL
the	NULL
fusion	NULL
process	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
13B8.2	NULL
MAb	NULL
inhibits	NULL
apoptosis	NULL
is	NULL
under	NULL
investigation	NULL
.	NULL

Our	NULL
collaborators	NULL
have	NULL
found	NULL
that	NULL
an	NULL
uncharacterized	NULL
protein	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
,	NULL
independently	NULL
of	NULL
the	NULL
cysteines	NULL
at	NULL
position	NULL
420	NULL
and	NULL
422	NULL
,	NULL
could	NULL
be	NULL
responsible	NULL
in	NULL
mediating	NULL
the	NULL
signal	NULL
transduction	NULL
event	NULL
associated	NULL
with	NULL
inhibition	NULL
of	NULL
HIV	NULL
replication	NULL
(	NULL
at	NULL
low	NULL
MOT	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

In	NULL
this	NULL
experimental	NULL
model	NULL
of	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
HIV	NULL
infection	NULL
primes	NULL
for	NULL
apoptotic	NULL
cell	NULL
death	NULL
was	NULL
related	NULL
to	NULL
the	NULL
expression	NULL
of	NULL
death	NULL
factors	NULL
that	NULL
regulate	NULL
apoptosis	NULL
.	NULL

Among	NULL
the	NULL
numerous	NULL
factors	NULL
that	NULL
regulate	NULL
cell	NULL
death	NULL
in	NULL
mammalian	NULL
cells	NULL
(	NULL
for	NULL
a	NULL
re-view	NULL
,	NULL
see	NULL
reference	NULL
56	NULL
)	NULL
,	NULL
the	NULL
Fas-Fas	NULL
ligand	NULL
system	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
T-cell	NULL
apoptosis	NULL
in	NULL
HIV-1-infected	NULL
patients	NULL
(	NULL
6	NULL
,	NULL
24	NULL
,	NULL
25	NULL
,	NULL
45	NULL
)	NULL
.	NULL

We	NULL
investigated	NULL
in	NULL
detail	NULL
the	NULL
role	NULL
of	NULL
Fas-Fas	NULL
ligand	NULL
in	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
in	NULL
wild-type	NULL
and	NULL
mutated	NULL
CD4	NULL
receptors	NULL
.	NULL

Neither	NULL
the	NULL
antagonistic	NULL
decoy	NULL
Fas	NULL
antibody	NULL
(	NULL
Fas-Fc	NULL
)	NULL
nor	NULL
the	NULL
IgG1	NULL
anti-Fas	NULL
antibody	NULL
clone	NULL
ZB4	NULL
prevented	NULL
apoptosis	NULL
induced	NULL
by	NULL
HIV	NULL
infection	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
(	NULL
32	NULL
)	NULL
,	NULL
this	NULL
suggests	NULL
that	NULL
HIV	NULL
-induced	NULL
apoptosis	NULL
is	NULL
not	NULL
mediated	NULL
by	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
in	NULL
lymphoblastoid	NULL
T-cell	NULL
lines	NULL
.	NULL

Intracellular	NULL
signaling	NULL
events	NULL
mediated	NULL
by	NULL
anti-Fas	NULL
MAb	NULL
ZB4	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
prevent	NULL
apoptosis	NULL
J.	NULL
ViRoL	NULL
.	NULL

induced	NULL
by	NULL
Fas-agonistic	NULL
antibody	NULL
clone	NULL
CH-11	NULL
.	NULL

However	NULL
,	NULL
in	NULL
acute	NULL
HIV	NULL
infection	NULL
,	NULL
anti-Fas	NULL
MAb	NULL
ZB4	NULL
potentiated	NULL
apoptotic	NULL
cell	NULL
death	NULL
,	NULL
suggesting	NULL
that	NULL
cross-linking	NULL
of	NULL
Fas	NULL
by	NULL
ZB4	NULL
may	NULL
be	NULL
more	NULL
efficient	NULL
in	NULL
delivering	NULL
a	NULL
death	NULL
signal	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Fadeel	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
have	NULL
reported	NULL
that	NULL
anti-Fas	NULL
IgG1	NULL
antibodies	NULL
recognizing	NULL
the	NULL
same	NULL
epitope	NULL
of	NULL
Fas/CD95	NULL
may	NULL
mediate	NULL
different	NULL
biological	NULL
effects	NULL
in	NULL
vitro	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
Tanaka	NULL
et	NULL
al	NULL
.	NULL

(	NULL
65	NULL
)	NULL
have	NULL
shown	NULL
that	NULL
signaling	NULL
through	NULL
the	NULL
soluble	NULL
form	NULL
of	NULL
Fas	NULL
ligand	NULL
and	NULL
signaling	NULL
through	NULL
the	NULL
insoluble	NULL
membrane-bound	NULL
Fas	NULL
ligand	NULL
have	NULL
different	NULL
outcomes	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
different	NULL
outcome	NULL
of	NULL
ZB4	NULL
signaling	NULL
in	NULL
uninfected	NULL
and	NULL
HIV-infected	NULL
cells	NULL
may	NULL
be	NULL
related	NULL
to	NULL
a	NULL
lower	NULL
threshold	NULL
for	NULL
apoptosis	NULL
or	NULL
to	NULL
the	NULL
recruitment	NULL
of	NULL
a	NULL
more	NULL
efficient	NULL
death-in-ducing	NULL
signaling	NULL
complex	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
ZB4	NULL
signaling	NULL
may	NULL
either	NULL
inhibit	NULL
(	NULL
Fas	NULL
antagonist	NULL
)	NULL
or	NULL
promote	NULL
(	NULL
HIV	NULL
infection	NULL
as	NULL
reported	NULL
here	NULL
)	NULL
apoptosis	NULL
depending	NULL
on	NULL
the	NULL
cellular	NULL
conditions	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
apoptosis	NULL
triggered	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
anti-Fas	NULL
MAb	NULL
ZB4	NULL
,	NULL
although	NULL
very	NULL
potent	NULL
at	NULL
increasing	NULL
the	NULL
extent	NULL
of	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
A2.01	NULL
cells	NULL
,	NULL
could	NULL
not	NULL
potentiate	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
primary	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
other	NULL
compensatory	NULL
mechanisms	NULL
are	NULL
operating	NULL
in	NULL
primary	NULL
cells	NULL
or	NULL
that	NULL
the	NULL
signal	NULL
transduction	NULL
pathway	NULL
responsible	NULL
for	NULL
the	NULL
increased	NULL
susceptibility	NULL
to	NULL
apoptosis	NULL
is	NULL
not	NULL
operational	NULL
in	NULL
the	NULL
primary	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
studies	NULL
demonstrate	NULL
the	NULL
role	NULL
of	NULL
the	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
in	NULL
transducing	NULL
a	NULL
signal	NULL
to	NULL
mediate	NULL
HIV-induced	NULL
apoptosis	NULL
,	NULL
independent	NULL
of	NULL
CD4-p56	NULL
``	NULL
**	NULL
signaling	NULL
.	NULL

CD4	NULL
signaling	NULL
was	NULL
critical	NULL
and	NULL
discriminatory	NULL
since	NULL
anti-CD4	NULL
antibody	NULL
13B8-2	NULL
but	NULL
not	NULL
OKT-4	NULL
could	NULL
abrogate	NULL
apoptosis	NULL
in	NULL
spite	NULL
of	NULL
intense	NULL
viral	NULL
replication	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
signaling	NULL
through	NULL
the	NULL
CDR-3	NULL
region	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
is	NULL
important	NULL
and	NULL
that	NULL
dimerization	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
may	NULL
be	NULL
required	NULL
in	NULL
this	NULL
process	NULL
.	NULL

Moreover	NULL
,	NULL
initial	NULL
signaling	NULL
mediated	NULL
through	NULL
the	NULL
CD4	NULL
receptor	NULL
was	NULL
a	NULL
primary	NULL
determinant	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
;	NULL
apoptosis	NULL
was	NULL
not	NULL
modulated	NULL
by	NULL
a	NULL
prolongated	NULL
presence	NULL
of	NULL
the	NULL
CD4	NULL
receptor	NULL
at	NULL
the	NULL
cell	NULL
surface	NULL
,	NULL
and	NULL
early	NULL
interference	NULL
with	NULL
CD4	NULL
signaling	NULL
using	NULL
anti-CD4	NULL
antibody	NULL
13B8-2	NULL
was	NULL
able	NULL
to	NULL
prevent	NULL
apoptosis	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

The	NULL
propensity	NULL
to	NULL
undergo	NULL
apoptosis	NULL
was	NULL
independent	NULL
of	NULL
Fas-Fas	NULL
ligand	NULL
interaction	NULL
.	NULL

However	NULL
,	NULL
a	NULL
role	NULL
for	NULL
Fas	NULL
signaling	NULL
could	NULL
still	NULL
be	NULL
invoked	NULL
by	NULL
the	NULL
potentiation	NULL
of	NULL
apoptosis	NULL
when	NULL
HIV-infected	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
the	NULL
anti-Fas	NULL
antibody	NULL
clone	NULL
ZB4	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
John	NULL
Reed	NULL
and	NULL
Shinichi	NULL
Kitada	NULL
for	NULL
Western	NULL
analysis	NULL
for	NULL
the	NULL
Bcl-2	NULL
family	NULL
protein	NULL
,	NULL
Jeanne	NULL
Aufderheide	NULL
and	NULL
Philip	NULL
Dao	NULL
for	NULL
the	NULL
p24	NULL
assays	NULL
,	NULL
and	NULL
Sara	NULL
Albanil	NULL
for	NULL
the	NULL
high-titer	NULL
stocks	NULL
of	NULL
HIV-11	NULL
,	NULL
;	NULL
.	NULL

We	NULL
acknowledge	NULL
the	NULL
assistance	NULL
of	NULL
Marjan	NULL
Hezareh	NULL
in	NULL
performing	NULL
EMSAs	NULL
and	NULL
Judy	NULL
Norberg	NULL
and	NULL
Michele	NULL
Lutz	NULL
in	NULL
the	NULL
flow	NULL
cytometry	NULL
analyses	NULL
.	NULL

We	NULL
thank	NULL
John	NULL
Guatelli	NULL
and	NULL
Aymeric	NULL
de	NULL
Parseval	NULL
for	NULL
comments	NULL
and	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
Center	NULL
for	NULL
AIDS	NULL
Research	NULL
and	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
AI	NULL
29164	NULL
and	NULL
CA	NULL
67394-02	NULL
to	NULL
J.C.	NULL
;	NULL
AI	NULL
27670	NULL
,	NULL
AI	NULL
38858	NULL
,	NULL
and	NULL
AI	NULL
36214	NULL
(	NULL
to	NULL
D.D.R	NULL
.	NULL
)	NULL

and	NULL
the	NULL
Research	NULL
Center	NULL
for	NULL
AIDS	NULL
and	NULL
HIV	NULL
Infection	NULL
of	NULL
the	NULL
San	NULL
Diego	NULL
Veterans	NULL
Affairs	NULL
Medical	NULL
Center	NULL
.	NULL

J.E	NULL
.	NULL

was	NULL
sponsored	NULL
by	NULL
a	NULL
Human	NULL
Science	NULL
Frontier	NULL
Program	NULL
fellowship	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Aiken	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Konner	NULL
,	NULL
N.	NULL
R.	NULL
Landau	NULL
,	NULL
M.	NULL
E.	NULL
Lenburg	NULL
,	NULL
and	NULL
D.	NULL
Trono	NULL
.	NULL

1994	NULL
.	NULL

Nef	NULL
induces	NULL
CD4	NULL
endocytosis	NULL
:	NULL
requirement	NULL
for	NULL
a	NULL
critical	NULL
motif	NULL
in	NULL
the	NULL
membrane-proximal	NULL
CD4	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Cell	NULL
76:853-864	NULL
.	NULL

2	NULL
.	NULL

Alnemri	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
D.	NULL
J.	NULL
Livingston	NULL
,	NULL
D.	NULL
W.	NULL
Nicholson	NULL
,	NULL
G.	NULL
Salvesen	NULL
,	NULL
N.	NULL
A.	NULL
Thorn-berry	NULL
,	NULL
W.	NULL
W.	NULL
Wong	NULL
,	NULL
and	NULL
J.	NULL
Yuan	NULL
.	NULL

1996	NULL
.	NULL

Human	NULL
ICE/CDE-3	NULL
protease	NULL
no-menclature	NULL
.	NULL

Cell	NULL
87:171	NULL
.	NULL

3	NULL
.	NULL

Ayyavoo	NULL
,	NULL
V.	NULL
,	NULL
A.	NULL
Mahboubi	NULL
,	NULL
S.	NULL
Mahalingam	NULL
,	NULL
R.	NULL
Ramalingan	NULL
,	NULL
S.	NULL
Kudchodkar	NULL
,	NULL
W.	NULL
V.	NULL
Williams	NULL
,	NULL
D.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
D.	NULL
B.	NULL
Weiner	NULL
.	NULL

1997	NULL
.	NULL

HIV-1	NULL
Vpr	NULL
suppresses	NULL
voL	NULL
.	NULL

72	NULL
,	NULL
1998	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27.	NULL
immune	NULL
activation	NULL
and	NULL
apoptosis	NULL
through	NULL
regulation	NULL
of	NULL
nuclear	NULL
factor	NULL
kB	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:1117-1123.	NULL
.	NULL

Baeuerle	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

NF-kB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87:13-	NULL
20.	NULL
.	NULL

Banda	NULL
,	NULL
N.	NULL
K.	NULL
,	NULL
J.	NULL
Bernier	NULL
,	NULL
D.	NULL
K.	NULL
Kurabara	NULL
,	NULL
R.	NULL
Kurrle	NULL
,	NULL
N.	NULL
Haigwood	NULL
,	NULL
R.	NULL
P.	NULL
Sekaly	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Finkel	NULL
.	NULL

1992	NULL
.	NULL

Crosslinking	NULL
CD4	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
gp120	NULL
primes	NULL
T	NULL
cells	NULL
for	NULL
activation-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

176:1099-1106.	NULL
.	NULL

Baumler	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
T.	NULL
Bobler	NULL
,	NULL
I.	NULL
Herr	NULL
,	NULL
A.	NULL
Benner	NULL
,	NULL
P.	NULL
H.	NULL
Krammer	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Debatin	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
CD95	NULL
(	NULL
APO-1/Fas	NULL
)	NULL
system	NULL
in	NULL
T	NULL
cells	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infected	NULL
children	NULL
.	NULL

Blood	NULL
88:1741-1746.	NULL
.	NULL

Beg	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
W.	NULL
C.	NULL
Sha	NULL
,	NULL
R.	NULL
T.	NULL
Bronson	NULL
,	NULL
S.	NULL
Ghosh	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1995	NULL
.	NULL

Embryonic	NULL
lethality	NULL
and	NULL
liver	NULL
degradation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
RelA	NULL
component	NULL
of	NULL
NF-kB	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
376:167-170.	NULL
.	NULL

Benkirane	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Corbeau	NULL
,	NULL
V.	NULL
Housset	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
antibody	NULL
that	NULL
binds	NULL
the	NULL
immunoglobulin	NULL
CDR3-like	NULL
region	NULL
of	NULL
the	NULL
CD4	NULL
molecule	NULL
inhibits	NULL
provirus	NULL
transcription	NULL
in	NULL
HIV-infected	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4909-4921.	NULL
.	NULL

Benkirane	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Hirn	NULL
,	NULL
D.	NULL
Carriere	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
epitope	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
CD4	NULL
molecule	NULL
:	NULL
antibodies	NULL
that	NULL
inhibit	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
gene	NULL
expression	NULL
bind	NULL
to	NULL
the	NULL
immunoglobulin	NULL
CDR3-like	NULL
region	NULL
of	NULL
CD4	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:6898-6903	NULL
.	NULL

Benkirane	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Schmid-Antomarchi	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
M.	NULL
Hirn	NULL
,	NULL
B.	NULL
Rossi	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
CD4	NULL
is	NULL
required	NULL
for	NULL
inhibition	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
by	NULL
antibodies	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
immunoglobulin	NULL
CDR3-like	NULL
region	NULL
in	NULL
domain	NULL
1	NULL
of	NULL
CD4	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:6904-6910	NULL
.	NULL

Briant	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
Signoret	NULL
,	NULL
M.	NULL
Gaubin	NULL
,	NULL
V.	NULL
Robert-Hebmann	NULL
,	NULL
X.	NULL
Zhang	NULL
,	NULL
R.	NULL
Murali	NULL
,	NULL
M.	NULL
I.	NULL
Greene	NULL
,	NULL
D.	NULL
Piatier-Tonneau	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1997	NULL
.	NULL

Transduction	NULL
of	NULL
an	NULL
activation	NULL
signal	NULL
that	NULL
follows	NULL
HIV-1	NULL
binding	NULL
to	NULL
CD4	NULL
and	NULL
CD4	NULL
dimerization	NULL
involves	NULL
the	NULL
immunoglobulin	NULL
CDR3-like	NULL
region	NULL
in	NULL
domain	NULL
1	NULL
of	NULL
CD4	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:19441-19450	NULL
.	NULL

Broder	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Berger	NULL
.	NULL

1993	NULL
.	NULL

CD4	NULL
molecules	NULL
with	NULL
a	NULL
diversity	NULL
of	NULL
mutations	NULL
encompassing	NULL
the	NULL
CDR3	NULL
region	NULL
efficiently	NULL
support	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
envelope	NULL
glycoprotein-mediated	NULL
cell	NULL
fusion	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:913-926	NULL
.	NULL

Camerini	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Seed	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
CD4	NULL
domain	NULL
important	NULL
for	NULL
HIV-mediated	NULL
syncytium	NULL
lies	NULL
outside	NULL
the	NULL
virus	NULL
binding	NULL
site	NULL
.	NULL

Cell	NULL
60:747-754	NULL
.	NULL

Chen	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
R.	NULL
T.	NULL
Gandhi	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1996	NULL
.	NULL

CD4	NULL
down-modulation	NULL
during	NULL
infection	NULL
of	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
involves	NULL
independent	NULL
activities	NULL
of	NULL
ypu	NULL
,	NULL
env	NULL
,	NULL
and	NULL
nef	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:6044-6053	NULL
.	NULL

Chen	NULL
,	NULL
M.-Y	NULL
.	NULL

,	NULL
F.	NULL
Maldarelli	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
K.	NULL
Strebel	NULL
.	NULL

1993	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Vpu	NULL
protein	NULL
induces	NULL
degradation	NULL
of	NULL
CD4	NULL
in	NULL
vitro	NULL
:	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
contributes	NULL
to	NULL
Vpu	NULL
sensitivity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:3877-3884	NULL
.	NULL

Chowers	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
M.	NULL
W.	NULL
Pandori	NULL
,	NULL
C.	NULL
A.	NULL
Spina	NULL
,	NULL
D.	NULL
D.	NULL
Richman	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Guatelli	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
growth	NULL
advantage	NULL
conferred	NULL
by	NULL
HIV-1	NULL
nef	NULL
is	NULL
determined	NULL
at	NULL
the	NULL
level	NULL
of	NULL
viral	NULL
DNA	NULL
formation	NULL
and	NULL
is	NULL
independent	NULL
of	NULL
CD4	NULL
downregu-lation	NULL
.	NULL

Virology	NULL
212:451-457	NULL
.	NULL

Chowers	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
C.	NULL
A.	NULL
Spina	NULL
,	NULL
T.	NULL
J.	NULL
Kwob	NULL
,	NULL
N.	NULL
J.	NULL
Fitch	NULL
,	NULL
D.	NULL
D.	NULL
Richman	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Guatelli	NULL
.	NULL

1994	NULL
.	NULL

Optimal	NULL
infectivity	NULL
in	NULL
vitro	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
requires	NULL
an	NULL
intact	NULL
nef	NULL
gene	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:2906-2914	NULL
.	NULL

Cinek	NULL
,	NULL
T.	NULL
,	NULL
I	NULL
Hilgert	NULL
,	NULL
and	NULL
V.	NULL
Horejsi	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
alternative	NULL
way	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
association	NULL
with	NULL
protein	NULL
kinases	NULL
of	NULL
the	NULL
Src	NULL
family	NULL
.	NULL

Immunogenetics	NULL
41:110-116	NULL
.	NULL

Coffin	NULL
,	NULL
J.	NULL
M.	NULL
1995	NULL
.	NULL

HIV	NULL
population	NULL
dynamics	NULL
in	NULL
vivo	NULL
:	NULL
implications	NULL
for	NULL
genetic	NULL
variation	NULL
,	NULL
pathogenesis	NULL
,	NULL
and	NULL
therapy	NULL
.	NULL

Science	NULL
267:483-489	NULL
.	NULL

Corbeil	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Richman	NULL
.	NULL

1995	NULL
.	NULL

Productive	NULL
infection	NULL
and	NULL
subsequent	NULL
interaction	NULL
of	NULL
CD4-gp120	NULL
at	NULL
the	NULL
cellular	NULL
membrane	NULL
is	NULL
required	NULL
for	NULL
HIV-induced	NULL
apoptosis	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

76:681-690	NULL
.	NULL

Corbeil	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Tremblay	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Richman	NULL
.	NULL

1996	NULL
.	NULL

HIV-induced	NULL
apoptosis	NULL
requires	NULL
the	NULL
CD4	NULL
receptor	NULL
cytoplasmic	NULL
tail	NULL
and	NULL
is	NULL
accelerated	NULL
by	NULL
interaction	NULL
of	NULL
CD4	NULL
with	NULL
pS6lck	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:39-48	NULL
.	NULL

Coudronni¢re	NULL
,	NULL
N.	NULL
,	NULL
J.	NULL
Corbeil	NULL
,	NULL
V.	NULL
Robert-Hebmann	NULL
,	NULL
J.-M.	NULL
Mesnard	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1998	NULL
.	NULL

The	NULL
Ick	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
antibody-mediated	NULL
CD4	NULL
(	NULL
CDR	NULL
loop	NULL
)	NULL
signal	NULL
transduction	NULL
that	NULL
inhibits	NULL
HIV-1	NULL
transcrip-tion	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28:1445-1457	NULL
.	NULL

Darzynkiewicz	NULL
,	NULL
Z.	NULL
,	NULL
X.	NULL
Li	NULL
,	NULL
and	NULL
J.	NULL
Gong	NULL
.	NULL

1994	NULL
.	NULL

Assays	NULL
of	NULL
cell	NULL
viability	NULL
:	NULL
discrimination	NULL
of	NULL
cells	NULL
dying	NULL
by	NULL
apoptosis	NULL
.	NULL

Methods	NULL
Cell	NULL
Biol	NULL
.	NULL

41:15-38	NULL
.	NULL

Estaquier	NULL
,	NULL
J.	NULL
,	NULL
T.	NULL
Idziorek	NULL
,	NULL
W.	NULL
Zou	NULL
,	NULL
D.	NULL
Emilie	NULL
,	NULL
C.	NULL
M.	NULL
Farber	NULL
,	NULL
J.	NULL
M.	NULL
Bourez	NULL
,	NULL
and	NULL
J.-C.	NULL
Ameisen	NULL
.	NULL

1995	NULL
.	NULL

Th1i/Th2	NULL
cytokines	NULL
and	NULL
T-cell	NULL
death	NULL
:	NULL
preventive	NULL
effect	NULL
of	NULL
IL-12	NULL
on	NULL
activation-induced	NULL
and	NULL
CD95	NULL
(	NULL
Fas/Apo-1	NULL
)	NULL
-mediated	NULL
apoptosis	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
from	NULL
HIV-infected	NULL
persons	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1759-1767.	NULL
.	NULL

Estaquier	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Tanaka	NULL
,	NULL
T.	NULL
Suda	NULL
,	NULL
S.	NULL
Nagata	NULL
,	NULL
P.	NULL
Golstein	NULL
,	NULL
and	NULL
J.-C.	NULL
Ameisen	NULL
.	NULL

1996	NULL
.	NULL

Fas-mediated	NULL
apoptosis	NULL
of	NULL
CD4+	NULL
and	NULL
CD8+	NULL
T	NULL
cells	NULL
from	NULL
human	NULL
immunodeficiency	NULL
virus-infected	NULL
persons	NULL
:	NULL
differential	NULL
in	NULL
vitro	NULL
preventive	NULL
effect	NULL
of	NULL
cytokines	NULL
and	NULL
protease	NULL
antagonists	NULL
.	NULL

Blood	NULL
87:4959-4966	NULL
.	NULL

Fadeel	NULL
,	NULL
B.	NULL
,	NULL
C.	NULL
J.	NULL
Thorpe	NULL
,	NULL
and	NULL
F.	NULL
Chioldi	NULL
.	NULL

1997	NULL
.	NULL

Anti-Fas	NULL
IgG1	NULL
antibodies	NULL
recognizing	NULL
the	NULL
same	NULL
epitope	NULL
of	NULL
Fas/APO-1	NULL
mediate	NULL
different	NULL
biological	NULL
effects	NULL
in	NULL
vitro	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

69:6898-6903	NULL
.	NULL

Finkel	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
G.	NULL
Tudor-Williams	NULL
,	NULL
N.	NULL
K.	NULL
Banda	NULL
,	NULL
M.	NULL
F.	NULL
Cotton	NULL
,	NULL
T.	NULL
Curiel	NULL
,	NULL
C.	NULL
MOLECULAR	NULL
ANALYSIS	NULL
OF	NULL
HIV-INDUCED	NULL
APOPTOSIS	NULL
28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

8071	NULL
Monks	NULL
,	NULL
T.	NULL
W.	NULL
Baba	NULL
,	NULL
R.	NULL
M.	NULL
Ruprecht	NULL
,	NULL
and	NULL
A.	NULL
Kupfer	NULL
.	NULL

1995	NULL
.	NULL

Apoptosis	NULL
occurs	NULL
predominantly	NULL
in	NULL
bystander	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
productively	NULL
infected	NULL
cells	NULL
of	NULL
HIV-	NULL
and	NULL
SIV-infected	NULL
lymph	NULL
nodes	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

1:129-134	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
T.	NULL
Theodore	NULL
,	NULL
M.	NULL
D.	NULL
Hoggan	NULL
,	NULL
M.	NULL
Martin	NULL
,	NULL
M.	NULL
Lightfoote	NULL
,	NULL
and	NULL
K.	NULL
Sell	NULL
.	NULL

1985	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
continuous	NULL
T-cell	NULL
line	NULL
susceptible	NULL
to	NULL
the	NULL
cytopathic	NULL
effects	NULL
of	NULL
the	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
-associated	NULL
retrovirus	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:4539-4543	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
M.	NULL
Powell	NULL
,	NULL
M.	NULL
Lightfoote	NULL
,	NULL
S.	NULL
Benn	NULL
,	NULL
M.	NULL
A.	NULL
Martin	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1985	NULL
.	NULL

Induction	NULL
of	NULL
HTLV-III/LAV	NULL
from	NULL
a	NULL
nonvirus	NULL
producing	NULL
T-cell	NULL
line	NULL
:	NULL
implications	NULL
for	NULL
latency	NULL
.	NULL

Science	NULL
231:600-602	NULL
.	NULL

Friedman	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
A.	NULL
P.	NULL
Reddy	NULL
,	NULL
R.	NULL
Wassell	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Jameson	NULL
,	NULL
and	NULL
R.	NULL
Korngold	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
human	NULL
CD4-CDR3-like	NULL
surface	NULL
involved	NULL
in	NULL
CD4+	NULL
T	NULL
cell	NULL
function	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:22635-22640	NULL
.	NULL

Glaichenhaus	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Shastri	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Turner	NULL
.	NULL

1991	NULL
.	NULL

Requirement	NULL
for	NULL
association	NULL
of	NULL
pS6lck	NULL
with	NULL
CD4	NULL
in	NULL
antigen-specific	NULL
signal	NULL
transduction	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
64:511-520	NULL
.	NULL

Glynn	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
D.	NULL
L.	NULL
McElligott	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Mosier	NULL
,	NULL
.	NULL

1996	NULL
.	NULL

Apoptosis	NULL
induced	NULL
by	NULL
HIV	NULL
infection	NULL
in	NULL
H9	NULL
T	NULL
cells	NULL
is	NULL
blocked	NULL
by	NULL
ICE-family	NULL
protease	NULL
inhibition	NULL
but	NULL
not	NULL
by	NULL
a	NULL
Fas	NULL
(	NULL
CD95	NULL
)	NULL
antagonist	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2754-2758	NULL
.	NULL

Gratton	NULL
,	NULL
S.	NULL
,	NULL
X.-J	NULL
.	NULL

Yao	NULL
,	NULL
S.	NULL
Venkatesan	NULL
,	NULL
E.	NULL
A.	NULL
Cohen	NULL
,	NULL
and	NULL
R.-P.	NULL
Sekaly	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
analysis	NULL
of	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD4	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
;	NULL
3305-3311	NULL
.	NULL

Grimm	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
K.	NULL
A.	NULL
Bauer	NULL
,	NULL
P.	NULL
A.	NULL
Baeuerle	NULL
,	NULL
and	NULL
K.	NULL
Schulze-Osthoff	NULL
.	NULL

1996	NULL
.	NULL

Bcl-2	NULL
down-regulates	NULL
the	NULL
activity	NULL
of	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
induced	NULL
upon	NULL
apoptosis	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

134:13-23	NULL
.	NULL

Groux	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
Torpier	NULL
,	NULL
D.	NULL
Monte	NULL
,	NULL
Y.	NULL
Mouton	NULL
,	NULL
A.	NULL
Capron	NULL
,	NULL
and	NULL
J.-C.	NULL
Ameisen	NULL
.	NULL

1992	NULL
.	NULL

Activation-induced	NULL
death	NULL
by	NULL
apoptosis	NULL
in	NULL
CD4+	NULL
T	NULL
cells	NULL
from	NULL
HIV-infected	NULL
asymptomatic	NULL
individuals	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175:331-340	NULL
.	NULL

Hashimoto	NULL
,	NULL
F.	NULL
,	NULL
N.	NULL
Oyaizu	NULL
,	NULL
S.	NULL
Kalyanaraman	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1997	NULL
.	NULL

Modulation	NULL
of	NULL
Bel-2	NULL
protein	NULL
by	NULL
CD4	NULL
cross-linking	NULL
:	NULL
a	NULL
possible	NULL
mechanism	NULL
for	NULL
lymphocyte	NULL
apoptosis	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
infection	NULL
and	NULL
for	NULL
rescue	NULL
of	NULL
apoptosis	NULL
by	NULL
interleukin-2	NULL
.	NULL

Blood	NULL
90:745-753	NULL
.	NULL

Heldin	NULL
,	NULL
C.-H.	NULL
1995	NULL
.	NULL

Dimerization	NULL
of	NULL
cell	NULL
surface	NULL
receptors	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

Cell	NULL
80:213-223	NULL
.	NULL

Henkart	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

1996	NULL
.	NULL

ICE	NULL
family	NULL
proteases	NULL
:	NULL
mediators	NULL
of	NULL
all	NULL
apoptotic	NULL
cell	NULL
death	NULL
.	NULL

Immunity	NULL
4195-201	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
D.	NULL
1997	NULL
.	NULL

Dynamics	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

99	NULL
;	NULL
2565-2567	NULL
.	NULL

Ho	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
A.	NULL
U.	NULL
Neumann	NULL
,	NULL
A.	NULL
S.	NULL
Perelson	NULL
,	NULL
W.	NULL
Chen	NULL
,	NULL
J.	NULL
M.	NULL
Leonard	NULL
,	NULL
and	NULL
M.	NULL
Markowitz	NULL
.	NULL

1995	NULL
.	NULL

Rapid	NULL
turnover	NULL
of	NULL
plasma	NULL
virions	NULL
and	NULL
CD4	NULL
lymphocytes	NULL
in	NULL
HIV-1	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:123-126	NULL
.	NULL

Hua	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Cullen	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
types	NULL
1	NULL
and	NULL
2	NULL
and	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
nef	NULL
use	NULL
distinct	NULL
but	NULL
overlapping	NULL
target	NULL
sites	NULL
for	NULL
downregulation	NULL
of	NULL
cell	NULL
surface	NULL
CD4	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:6742-6748	NULL
.	NULL

Idziorek	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Estaquier	NULL
,	NULL
F.	NULL
de	NULL
Bels	NULL
,	NULL
and	NULL
J.-C.	NULL
Ameisen	NULL
.	NULL

1995	NULL
.	NULL

YOPRO-1	NULL
permits	NULL
cytofluorometric	NULL
analysis	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
apoptosis	NULL
)	NULL
without	NULL
interfering	NULL
with	NULL
cell	NULL
viability	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
185:249-258	NULL
.	NULL

Jacotot	NULL
,	NULL
E.	NULL
,	NULL
B.	NULL
Krust	NULL
,	NULL
C.	NULL
Callebaut	NULL
,	NULL
A.	NULL
G.	NULL
Laurent-Crowford	NULL
,	NULL
J.	NULL
Blanco	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
.	NULL

1997	NULL
.	NULL

HIV-1	NULL
envelope	NULL
glycoproteins-mediated	NULL
apoptosis	NULL
is	NULL
regulated	NULL
by	NULL
CD4	NULL
dependent	NULL
and	NULL
independent	NULL
mechanisms	NULL
.	NULL

Apoptosis	NULL
2	NULL
:	NULL
1997	NULL
.	NULL

Kiirber	NULL
,	NULL
G.	NULL
1931	NULL
.	NULL

Beitrige	NULL
zur	NULL
kollektiven	NULL
Behandlung	NULL
pharmakologisher	NULL
Reihenversuche	NULL
.	NULL

Arch	NULL
.	NULL

Exp	NULL
.	NULL

Pathol	NULL
.	NULL

Pharmakol	NULL
.	NULL

162:480-483	NULL
.	NULL

Katsikis	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
E.	NULL
S.	NULL
Wunderlich	NULL
,	NULL
C.	NULL
A.	NULL
Smith	NULL
,	NULL
L.	NULL
A.	NULL
Hertzenberg	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Hertzenberg	NULL
.	NULL

1995	NULL
.	NULL

Fas	NULL
antigen	NULL
stimulation	NULL
induces	NULL
marked	NULL
apoptosis	NULL
of	NULL
T	NULL
lymphocytes	NULL
in	NULL
HIV-infected	NULL
individuals	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:2029-2036	NULL
.	NULL

Killeen	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

Helper	NULL
T-cell	NULL
development	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD4-p56lck	NULL
association	NULL
.	NULL

Nature	NULL
364:729-732	NULL
.	NULL

Kroemer	NULL
,	NULL
G.	NULL
1997	NULL
.	NULL

The	NULL
proto-oncogene	NULL
Bcl-2	NULL
and	NULL
its	NULL
role	NULL
in	NULL
regulating	NULL
apoptosis	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:614-620	NULL
.	NULL

Langedijk	NULL
,	NULL
J.	NULL
P.	NULL
M.	NULL
,	NULL
W.	NULL
C.	NULL
Puijk	NULL
,	NULL
W.	NULL
Paul	NULL
van	NULL
Hoorn	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Meloens	NULL
.	NULL

1993	NULL
.	NULL

Location	NULL
of	NULL
CD4	NULL
dimerization	NULL
site	NULL
explains	NULL
critical	NULL
role	NULL
of	NULL
CDR3-like	NULL
region	NULL
in	NULL
HIV-1	NULL
infection	NULL
and	NULL
T-cell	NULL
activation	NULL
and	NULL
implies	NULL
a	NULL
model	NULL
for	NULL
complex	NULL
of	NULL
coreceptor-MHC	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:16875-16878	NULL
.	NULL

Laurent-Crawford	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
B.	NULL
Krust	NULL
,	NULL
S.	NULL
Muller	NULL
,	NULL
Y.	NULL
Riviere	NULL
,	NULL
M.-A	NULL
.	NULL

Rey-Cuille	NULL
,	NULL
J.-M.	NULL
Bechet	NULL
,	NULL
L.	NULL
Montagnier	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
cytopathic	NULL
effect	NULL
of	NULL
HIV	NULL
is	NULL
associated	NULL
with	NULL
apoptosis	NULL
.	NULL

Virology	NULL
185:829-839	NULL
.	NULL

Laurent-Crawford	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
B.	NULL
Krust	NULL
,	NULL
Y.	NULL
Riviere	NULL
,	NULL
C.	NULL
Desgranges	NULL
,	NULL
S.	NULL
Muller	NULL
,	NULL
M.-P.	NULL
Kieny	NULL
,	NULL
C.	NULL
Dauguet	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Hovanessian	NULL
.	NULL

1993	NULL
.	NULL

Membrane	NULL
expression	NULL
of	NULL
HIV	NULL
envelope	NULL
glycoproteins	NULL
triggers	NULL
apoptosis	NULL
in	NULL
CD4	NULL
cells	NULL
.	NULL

AIDS	NULL
Res	NULL
.	NULL

Hum	NULL
.	NULL

Retroviruses	NULL
9:761-773	NULL
.	NULL

Lemasson	NULL
,	NULL
I.	NULL
,	NULL
L.	NULL
Briant	NULL
,	NULL
B.	NULL
Hague	NULL
,	NULL
N.	NULL
Coudronniere	NULL
,	NULL
L.	NULL
Heron	NULL
,	NULL
C.	NULL
David	NULL
,	NULL
C.	NULL
Rebouissou	NULL
,	NULL
T.	NULL
Kindt	NULL
,	NULL
and	NULL
C.	NULL
Devaux	NULL
.	NULL

1996	NULL
.	NULL

An	NULL
antibody	NULL
that	NULL
binds	NULL
domain	NULL
1	NULL
of	NULL
CD4	NULL
inhibits	NULL
replication	NULL
of	NULL
HIV-1	NULL
,	NULL
but	NULL
not	NULL
HTLV-I	NULL
,	NULL
in	NULL
a	NULL
CD4-positive/	NULL
pS6lck-negative	NULL
HTLV-I-transformed	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:859-865	NULL
.	NULL

Liu	NULL
,	NULL
Z.-G.	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1996	NULL
.	NULL

Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-kB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87:565-576	NULL
.	NULL

Mangasarian	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Foti	NULL
,	NULL
C.	NULL
Aiken	NULL
,	NULL
D.	NULL
Chin	NULL
,	NULL
and	NULL
J.-L.	NULL
Carpentier	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
HIV	NULL
Nef	NULL
protein	NULL
acts	NULL
as	NULL
a	NULL
connector	NULL
with	NULL
sorting	NULL
pathways	NULL
in	NULL
the	NULL
golgi	NULL
and	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
.	NULL

Immunity	NULL
6:67-77	NULL
.	NULL

8072	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

MOUTOUH	NULL
ET	NULL
AL	NULL
.	NULL

McGuire	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
Iacobelli	NULL
.	NULL

1997	NULL
.	NULL

Involvement	NULL
of	NULL
Rel	NULL
,	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
in	NULL
binding	NULL
activity	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
CD28	NULL
response	NULL
clement/	NULL
AP-1	NULL
sequence	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:1319-1327	NULL
.	NULL

Muro-Cacho	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
G.	NULL
Pantaleo	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
apoptosis	NULL
in	NULL
lymph	NULL
nodes	NULL
of	NULL
HIV-infected	NULL
persons	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:5555-5566	NULL
.	NULL

Nagata	NULL
,	NULL
S.	NULL
1997	NULL
.	NULL

Apoptosis	NULL
by	NULL
death	NULL
factor	NULL
.	NULL

Cell	NULL
88:355-365	NULL
.	NULL

Oyaizu	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Adachi	NULL
,	NULL
F.	NULL
Hashimoto	NULL
,	NULL
T.	NULL
W.	NULL
McCloskey	NULL
,	NULL
N.	NULL
Hosaka	NULL
,	NULL
N.	NULL
Kayagaki	NULL
,	NULL
H.	NULL
Yagita	NULL
,	NULL
and	NULL
S.	NULL
Pahwa	NULL
.	NULL

1997	NULL
.	NULL

Monocytes	NULL
express	NULL
Fas	NULL
ligand	NULL
upon	NULL
CD4	NULL
cross-linking	NULL
and	NULL
induce	NULL
CD4+	NULL
T	NULL
cell	NULL
apoptosis	NULL
:	NULL
a	NULL
possible	NULL
mechanism	NULL
of	NULL
bystander	NULL
cell	NULL
death	NULL
in	NULL
HIV	NULL
infection	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

158:2456-2463	NULL
.	NULL

Pelchen-Matthews	NULL
,	NULL
A.	NULL
,	NULL
I.	NULL
Boulet	NULL
,	NULL
D.	NULL
R.	NULL
Littman	NULL
,	NULL
R.	NULL
Fagard	NULL
,	NULL
and	NULL
M.	NULL
Marsh	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
pS6lck	NULL
inhibits	NULL
CD4	NULL
endocytosis	NULL
by	NULL
preventing	NULL
entry	NULL
of	NULL
CD4	NULL
into	NULL
coated	NULL
pits	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

117:279-290	NULL
.	NULL

Rogel	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
L.	NULL
I.	NULL
Wu	NULL
,	NULL
and	NULL
M.	NULL
Emerman	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
vpr	NULL
gene	NULL
prevents	NULL
cell	NULL
proliferation	NULL
during	NULL
chronic	NULL
infection	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:882-888	NULL
.	NULL

Salghetti	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Mariani	NULL
,	NULL
and	NULL
J.	NULL
Skowronski	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
nef	NULL
and	NULL
pS6lck	NULL
protein-tyrosine	NULL
kinase	NULL
interact	NULL
with	NULL
a	NULL
common	NULL
element	NULL
in	NULL
CD4	NULL
cytoplasmic	NULL
tail	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
;	NULL
349-353	NULL
.	NULL

Spina	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
T.	NULL
J.	NULL
Kwob	NULL
,	NULL
M.	NULL
Y.	NULL
Chowers	NULL
,	NULL
J.	NULL
C.	NULL
Guatelli	NULL
,	NULL
and	NULL
D.	NULL
D.	NULL
Richman	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
nef	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
replication	NULL
from	NULL
primary	NULL
quiescent	NULL
CD4	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179:115-123	NULL
.	NULL

Stewart	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
B.	NULL
Poon	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
M.	NULL
Jowett	NULL
,	NULL
and	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
.	NULL

1997	NULL
.	NULL

Human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
Vpr	NULL
induces	NULL
apoptosis	NULL
following	NULL
cell	NULL
cycle	NULL
arrest	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

71:5579-5592	NULL
.	NULL

Straus	NULL
,	NULL
D.	NULL
B.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1992	NULL
.	NULL

Genetic	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
Ick	NULL
tyrosine	NULL
kinase	NULL
in	NULL
signal	NULL
transduction	NULL
through	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Cell	NULL
70:585-593	NULL
.	NULL

Susin	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
N.	NULL
Zamzami	NULL
,	NULL
M.	NULL
Castedo	NULL
,	NULL
E.	NULL
Daugas	NULL
,	NULL
H.	NULL
G.	NULL
Wang	NULL
,	NULL
S.	NULL
Geley	NULL
,	NULL
F.	NULL
Fassy	NULL
,	NULL
J.	NULL
C.	NULL
Reed	NULL
,	NULL
and	NULL
G.	NULL
Kroemer	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
central	NULL
executioner	NULL
of	NULL
apoptosis	NULL
:	NULL
multiple	NULL
connections	NULL
between	NULL
protease	NULL
activation	NULL
and	NULL
mitochondria	NULL
in	NULL
Fas/APO-1/CD95-	NULL
and	NULL
ceramide-induced	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:25-37	NULL
.	NULL

Tanaka	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Itai	NULL
,	NULL
M.	NULL
Adachi	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1998	NULL
.	NULL

Downregulation	NULL
of	NULL
Fas	NULL
66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

ligand	NULL
by	NULL
shedding	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

4:31-36	NULL
.	NULL

Telford	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
L.	NULL
E.	NULL
King	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Fraker	NULL
.	NULL

1992	NULL
.	NULL

Comparative	NULL
evaluation	NULL
of	NULL
several	NULL
DNA	NULL
binding	NULL
dyes	NULL
in	NULL
the	NULL
detection	NULL
of	NULL
apoptosis-associated	NULL
chromatin	NULL
degradation	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Cytometry	NULL
13:137-142	NULL
.	NULL

Terai	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
S.	NULL
Kornbluth	NULL
,	NULL
C.	NULL
D.	NULL
Pauza	NULL
,	NULL
D.	NULL
D.	NULL
Richman	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Carson	NULL
.	NULL

1991	NULL
.	NULL

Apoptosis	NULL
as	NULL
a	NULL
mechanism	NULL
of	NULL
cell	NULL
death	NULL
in	NULL
cultured	NULL
T	NULL
lymphoblasts	NULL
acutely	NULL
infected	NULL
with	NULL
HIV-1	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

87:1710-1715	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B	NULL
.	NULL

1995	NULL
.	NULL

Apoptosis	NULL
in	NULL
the	NULL
pathogenesis	NULL
and	NULL
treatment	NULL
of	NULL
disease	NULL
.	NULL

Science	NULL
267:1456-1462	NULL
.	NULL

Turner	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
M.	NULL
H.	NULL
Brodsky	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
Irving	NULL
,	NULL
S.	NULL
D.	NULL
Levin	NULL
,	NULL
R.	NULL
M.	NULL
Perlmutter	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1990	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
unique	NULL
N-terminal	NULL
region	NULL
of	NULL
tyrosine	NULL
kinase	NULL
pS6lck	NULL
with	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
CD4	NULL
and	NULL
CD8	NULL
is	NULL
mediated	NULL
by	NULL
cysteine	NULL
motifs	NULL
.	NULL

Cell	NULL
60:755-765	NULL
.	NULL

Veillette	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
A.	NULL
Bookman	NULL
,	NULL
E.	NULL
M.	NULL
Horak	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Bolen	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
CD4	NULL
and	NULL
CD8	NULL
T	NULL
cell	NULL
surface	NULL
antigens	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
internal	NULL
membrane	NULL
tyrosine-protein	NULL
kinase	NULL
pS6lck	NULL
.	NULL

Cell	NULL
55:301-308	NULL
.	NULL

Veillette	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
A.	NULL
Bookman	NULL
,	NULL
E.	NULL
M.	NULL
Horak	NULL
,	NULL
L.	NULL
E.	NULL
Samelson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

B.	NULL
Bolen	NULL
.	NULL

1989	NULL
.	NULL

Signal	NULL
transduction	NULL
through	NULL
the	NULL
CD4	NULL
receptors	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
internal	NULL
membrane	NULL
tyrosine-protein	NULL
kinase	NULL
pS6lck	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
338:257-259	NULL
.	NULL

Wei	NULL
,	NULL
X.	NULL
,	NULL
S.	NULL
K.	NULL
Ghosh	NULL
,	NULL
M.	NULL
E.	NULL
Taylor	NULL
,	NULL
V.	NULL
A.	NULL
Johnson	NULL
,	NULL
E.	NULL
A.	NULL
Emini	NULL
,	NULL
P.	NULL
Deutsch	NULL
,	NULL
J.	NULL
D.	NULL
Lifson	NULL
,	NULL
S.	NULL
Bonhoeffer	NULL
,	NULL
M.	NULL
A.	NULL
Nowak	NULL
,	NULL
B.	NULL
H.	NULL
Hahn	NULL
,	NULL
M.	NULL
S.	NULL
Saag	NULL
,	NULL
and	NULL
G.	NULL
M.	NULL
Shaw	NULL
.	NULL

1995	NULL
.	NULL

Viral	NULL
dynamics	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:117-122	NULL
.	NULL

Weiss	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1994	NULL
.	NULL

Signal	NULL
transduction	NULL
by	NULL
lymphocyte	NULL
antigen	NULL
receptors	NULL
.	NULL

Cell	NULL
76:263-274	NULL
.	NULL

Westendorp	NULL
,	NULL
M.	NULL
O.	NULL
,	NULL
R.	NULL
Frank	NULL
,	NULL
C.	NULL
Ochsenbauer	NULL
,	NULL
K.	NULL
Stricker	NULL
,	NULL
J.	NULL
Dhein	NULL
,	NULL
H.	NULL
Walcazak	NULL
,	NULL
K.-M.	NULL
Debatin	NULL
,	NULL
and	NULL
P.	NULL
H.	NULL
Krammer	NULL
.	NULL

1995	NULL
.	NULL

Sensitization	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
CD95-mediated	NULL
apoptosis	NULL
by	NULL
HIV-1	NULL
tat	NULL
and	NULL
gp120	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
375:497-500	NULL
.	NULL

Xu	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
D.	NULL
R.	NULL
Littman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
kinase-independent	NULL
function	NULL
of	NULL
Ick	NULL
in	NULL
potentiating	NULL
antigen-specific	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Cell	NULL
1993:633-643	NULL
.	NULL

Yee	NULL
,	NULL
J.-K.	NULL
,	NULL
A.	NULL
Miyanchara	NULL
,	NULL
P.	NULL
LaPorte	NULL
,	NULL
K.	NULL
Bouic	NULL
,	NULL
J.	NULL
C.	NULL
Burns	NULL
,	NULL
and	NULL
T.	NULL
Fried-mann	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
general	NULL
method	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
high-titer	NULL
,	NULL
pantropic	NULL
retroviral	NULL
vectors	NULL
:	NULL
highly	NULL
efficient	NULL
infection	NULL
of	NULL
primary	NULL
hepatocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:9564-9568	NULL
.	NULL

